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CHAPTER I 
INTRODUCTION 
Morphine has been characterized as possessing respiratory 
depressant qualities since the first studies of Gscheidlen in 1869 
(see 7). Studies in the ensuing years have supported the finding that 
the action of morphine on the respiratory controller is depressive in 
nature, but upon close scrutiny, many of them prove to be ancedotal in 
nature. In almost all, morphine is administered via bolus injection, 
the disadvantage of which is the initial respiratory and circulatory 
depression that occurs wh~ch may be severe enough to compromise the 
physiological state of the preparation throughout the remainder of the 
experiment (6). The administration of anesthesia may affect 
respiratory related activity in several ways, a factor ignored in the 
majority of studies. Lastly, though a few studies have alluded to the 
ability of morphine to attenuate the abnormal ventilatory pattern of 
apneusis (4,31), the advantages of such a model in studying the 
respiratory effects of morphine have not been exploited. In light of 
the foregoing considerations, the present study was undertaken to 
study the alterations of two respiratory patterns, eupnea and 
apneusis, induced by constant intravenous infusion of morphine in the 
decerebrate cat. 
l 
CHAPTER II 
LITERATURE REVIEW 
A. Respiratory Effects of Morphine and Related Substances 
Cushny (7), in his first studies of the action of various 
pharmacological agents on the respiratory center, cited Gscheidlen as 
being the first experimental investigator to describe the depressant 
action of morphine on respiration. Though Gscheidlen attributed the 
decrease in ventilation as being due to a decrease in the frequency of 
breathing, other researchers of the period ascribed the ventilatory 
depression to be a resul~ of both decreased frequency and depth of 
• 
respiration. Wood and Cerna (see-7) in the dog, injected very large 
doses of morphine intravenously which caused respiration to nearly 
cease, but renewed injections of morphine increased it in rate and 
depth, at the same time inducing convulsions. Filehne (see 7) 
previously noted the same phenomena in the rabbit, respiration being 
slowed at first and later becoming more frequent in the stage of 
increased reflex excitability (convulsions), though even during this 
stage ventilation was reduced from the control value. The mechanism 
of action by which morphine exerted these effects was thought to be a 
"lowered susceptibility of the respiratory center to a carbon dioxide 
stimulus." 
Cushny's own studies on decerebrate rabbits, injected with 1-2 mg 
of morphine intravenously, showed morphine reduced the rate without 
lessening the depth to a corresponding extent. When challenged with 
2 
carbon dioxide (C0/2), he hypothesized the center could not respond 
rate but could still increase the depth of 
likened this to the results of C0/2 challenge 
with an increase in 
respiration. 
after vagotomy, 
Cushny 
in which an increase in the depth of respiration 
without significant acceleration. From this, he 
action of C0/2 on the respiratory center to be 
occurred 
concluded 
but 
the 
augmentation of depth, but not frequency, since acceleration could 
occur only as long as the center received impulses from the lungs 
through afferent pathways. Theoretically, then, because of the 
similarity in the responses to C0/2 challenge between the vagotomized 
and morphinized animal, it was possible that morphine might act on the 
respiratory center by _"bl~king the passage through the synapse of 
afferent impulses to the respiratory center." This seemed an 
attractive hypothesis, for it would also explain the action of 
morphine in cough. 
Experiments performed by Cushny on decerebrate, vagotomized 
rabbits, 
seen in 
morphine 
however, 
rabbits 
for the 
produced 
with the 
rabbits 
the same effects on respiration as those 
vagi intact (although the fatal dose of 
was much reduced when the yagi were cut). 
Cushny's conclusion was that morphine did not lessen the rate merely 
by preventing the access of impulses to the center from the lungs. 
The changes in respiration produced by morphine might be regarded as a 
secondary result of the action on the center and not the prime factor. 
Cushny also reported on two experiments done with cats, in which 
he showed that 1-2 mg of morphine acted on the respiration of 
decerebrate cats in the same way as in decerebrated rabbits, and on 
3 
the whole appeared to depress it more strongly. 
In his discussion, Cushny states that morphine (in addition to 
other drugs he examined) affected the rate of respiration more 
frequently than the depth, the change in frequency usually being 
opposite in direction to that in depth. Ruling out the possibilities 
that the alterations in respiration caused by morphine were entirely 
due to either a depressed sensitivity of the respiratory center to a 
C0/2 stimulus or by alteration of afferent impulses to the center, he 
concluded morphine to have a more fundamental action on the intrinsic 
respiratory rhythmic process on which both of those influences act. 
Barbour (1) in 1914 mentions briefly the work of Filehne and his 
production of a periodic r~piratory pattern in morphinized rabbits, 
and states that most researchers thought Filehne to be "mistaken not 
only in the interpretation of his results, but also in his conclusion 
that all periodic respiration had a basis in circulatory changes." 
Periodic respiratory patterns were Barbour's main focus in his 
publication, but he produced the patterns by administering morphine to 
etherized cats, both vagotomized and with vagi intact. His first 
experiment, in which a 2 kg vagotomized cat was injected i.v. with 20 
mg of morphine produced "a striking alteration both in respiration and 
blood pressure. The former shows at once a great decrease in rate 
which may or may not be accompanied by a compensatory increase in 
excursion. A periodic character (cluster type) may be assumed within 
5 minutes, or at almost anytime thereafter; but even under repeated 
doses it may never appear at all." Similar results were obtained in 
two other experiments, though in one case the vagi were left intact 
4 
until the periodicity in respiration was well established. Neither 
the cutting of one nor of both vagi in this experiment affected 
appreciably the course of respiration. Lastly, in an experiment in 
which a 5 kg cat received 40 mg of morphine, a periodic respiration 
which persisted over a considerable period of time was produced. 
Barbour's primary objective in these few experiments was not to 
examine the effects of morphine per se, but to examine different types 
of periodic respiration and advance theories of their etiology on the 
basis of circulatory changes. In retrospect, the value of these 
experiments lie not in his explanations of the role of the 
"respiratory hormone" but in his demonstration of the alteration of 
eupneic patterns by morphine.;' 
Jackson (23) in 1914 was another early investigator who examined 
the effects of opiate drugs used on the lungs, particularly the 
bronchioles. His experimental preparation consisted of etherized 
dogs, which were subsequently pithed, and respired artificially by 
negative pressure. A glass window was placed directly over the heart 
to observe movement of both the heart and lung. 
Two important findings r~aulted from Jackson's work. Firat, the 
discovery that larger doses of morphine caused bronchoconstriction in 
normal and atropinized dogs was confirmation of the work of Dixon and 
Brodie (10) who studied the action of morphine on bronchioles in the 
cat. They had found that large injections of morphine into cats 
caused a considerable constriction of the bronchiol muscle, regardless 
whether the vagi were intact or not. Thus, the oft-observed 
convulsions with larger doses of morphine could be caused by, or 
5 
6 
increased through, an asphyxia resulting from bronchoconstriction. 
This would explain an earlier observation by Jackson that the 
injection of epinephrine often revived and saved animals with morphine 
poisoning, since epinephrine was a bronchodilator. 
Secondly, in his dog model, Jackson corroborated the finding that 
periodic respiration is one of the most typical symptoms of morphine 
poisoning; its appearance is due to a direct action by morphine on the 
re~piratory system. 
A short time after Cushny published his first studies on the 
pharmacology of the respiratory system, Cushny and Lieb (8) presented 
a second series in which the effects of morphine were examined in more 
detail. Three of the experiments deserve mention. In the first, 3 mg 
of morphine were administered to a rabbit (weight unspecified) 
anesthetized with urethane. The frequency of respiration dropped from 
68 breaths/minute to 35 breaths/minute within 6 minutes of the 
injection, while the C0/2 content of the blood remained nearly 
unchanged. Within 30 
breaths/minute and the 
minutes the frequency had dropped to 19 
C0/2 content increased to 65% of the control 
value. The authors concluded, "This increase in C0/2, which occurs 
only some time after the onset of slowing, indicates that the 
hypercapnia is the result of the decreased ventilation and not the 
cause of it." 
Two other experiments were performed on decerebrate cats, in 
which an unspecified amount of morphine was administered, but in an 
amount sufficient to cause convulsions. Frequency and ventilation 
were both above normal, but with smaller doses, the rate and volume 
7 
were both decreased (as it was in the rabbit). Though the data from 
the two experiments was not publi~hed, the authors stated the changes 
in C0/2 content of the blood were much the same as in the rabbit. 
Cushny and Lieb concluded that morphine decreases frequency 
without affecting depth, and the reaction to C0/2 inhalation under 
morphine was of the same type as normal: the respiration increased in 
both rate and depth (though of smaller magnitude than in the normal 
animal). The slowing of the respiration under morphine, they felt, 
could be ascribed to an action on the intrinsic rhythm of the 
respiratory center which is rendered slower. In death from morphine 
poisoning, the respiration failed because the intrinsic rhythm of the 
center was abolished. 
• 
Schmidt and Harer (39) were the first investigators to view the 
action of morphine and related narcotics not as an unselective effect 
on the respiratory center, but as exerting specific actions on either 
the inspiratory or expiratory mechanism. Though at that time they 
knew of "no convincing evidence to indicate either the existence of 
distinct centers c~ntrolling inspiration and expiration, or the 
possibility of a truly selective action by drugs on one or the other 
phase of respiration," they designed experiments to study the 
possibility of such a selective action. 
In vagi intact decerebrate cats, they found expiration to become 
passive following intravenous or intramuscular injection of morphine. 
If the dose was sufficiently high (1-20 mg), ·inspiration was deeper 
than before. Thus, while morphine decreased the rate very definitely, 
the volume of each breath had slightly increased. It would be 
8 
possible, then, for the slower deeper breathing after morphine to be 
almost as efficient as the ventilation preceding the morphine. After 
cutting the vagi, expiration always became definitely active, and 
frequently respiration became a series of inspiratory pauses, broken 
by active expirations. 
In giving successive doses of morphine (5-10 mg at a time) to a 
decerebrate cat, there usually occurred, instead of a progressive 
depression, a return of active expiration and acceleration in rate, 
regardless of whether the vagi were intact or cut. They observed a 
maximum reduction of rate, with completely passive expiration, to 
usually follow 20 mg if the vagi were intact, or 5 mg if they were 
cut. Following 60 mg, convulsions often appeared, accompanied by 
active expirations and an accelerated rate. Following 60 mg, tetanic 
convulsions often appeared, accompanied by active expirations and an 
accelerated rate. In one experiment, tetanic convulsions occurred 
after 270 mg, following a period of dyspnea. Schmidt and Harer felt 
these convulsions from large doses pointed to a stimulant action on 
the spinal cord, which 
which followed smaller 
apparently overcomes the central depression 
doses. They remarked: "The extremely slow 
rate, culminating in respiratory failure, which is so characteristic 
of advanced morphine poisoning in other animals, occurred only if a 
fairly large dose (30-60 mg) was injected rapidly, and was always 
accompanied by marked circulatory depression. As long. as blood 
presure remained high, it was impossible to produce respiratory 
failure by morphine alone in the decerebrated cat." 
On the basis of the results of their experiments, in which 
9 
morphine decreased selectively the rate without affecting the depth of 
breathing, Schmidt and Harer concluded morphine to have an apparently 
selective action on the central expiratory mechanism of the cat, and 
that whenever the rate was diminished, expiration was passive. In 
their experiments, the extremely siow rate, culminating in respiratory 
failure, seemed to be due to depression of circulation rather than of 
respiration directly; they did not regard it as being typical of 
morphine's action on respiration in the cat. 
Dripps and Dumke (11) examined the effects of several different 
narcotics, morphine being one of them, on the balance between central 
and peripheral chemoreceptor control of respiration. Using 
decerebrate dogs and cats, morphine sulfate was injected 
intramuscularly in stepwise doses to a maximum of 16 mg/kg. Not only 
was there depression of the respiratory response to a C0/2 challenge, 
there was also a definite relationship between the degree of 
depression and depth of narcosis. In addition, minute volume of 
breathing 
narcosis. 
was decreased, again correlating with the degree of 
Peripheral chemoreceptor sensitivity of the decerebrate 
cats under morphine appeared to be increased, and morphine decreased 
the C0/2 response to a greater extent in the cat than in the dog. 
These investigators believed exaggeration of chemoreflex 
functions by certain narcotics could be produced simply by depression 
of the center's ability to respond directly to C0/2 and did not 
necessarily require an actual increase in reflex excitability. They 
had no data bearing on the explanation for this decreased responsivity 
of the respiratory center to C0/2 (to the point of complete 
10 
disappearance) while peripheral 
(as was 
chemoreceptor reflexes 
the case with morphine). 
might be 
In their relatively increased 
opinion, this increase in sensitivity (as measured by the response to 
sodium cyanide) was probably due, at least to some extent, to the 
presence of anoxemia resulting from repiratory depression. Removal of 
anoxemia by inhalation of oxygen restored the sensitivity to near 
normal. 
Dripps 
data it is 
effect of 
respiration. 
and Dumke concluded with these remarks: "From all of the 
evident that no single pattern can be described for the 
anesthetics (including morphine) on the control of 
This is a complex resultant of many forces." 
The most complete study on the influence of morphine on 
respiratory patterns was done by Breckenridge and Hoff (4) in 1951. A 
number of different dog models were studied: unanesthetized dogs 
(n=10), decerebrate dogs with vagi intact (n=13) or cut (n=S), 
apneustic dogs produced by midpontine section followed by vagotomy 
(n=13), and dogs with the brainstem sectioned at the upper level of 
the medulla and the vagi cut (n=24). In all experiments morphine 
sulfate was administered intravenously as bolus injections. 
In unanesthetized dogs, the most consistent respiratory effect 
was the production of a "sighing rhythm" after a short period of 
tachypnea, as well as a slight reduction in rate and amplitude of 
eupnea. Another phenomena observed was a post-sigh apnea, referred to 
as post-sigh inhibition. In decerebrate preparations in which the 
vagi were left intact, the results were almost identical with those in 
the normal animal except that the stimulation of the sighing type of 
breathing, the post-sigh inhibition, and the consequent depression of 
eupnea were more pronounced. After sections within the pons and 
vagotomy, apneustic breathi~g developed, characterized by periods of 
inspiratory breath-holding alternating with expiratory apnea. When 
morphine was given to animals in this apneustic pattern, a 
characteristic increase in the rate of the slow rhythm of respiration 
occurred, expressed as an acceleration of apneustic breathing. 
Concomitantly, a diminution in this duration of the inspiratory 
breath-holding pattern occurred, though only rarely was it possible to 
completely abolish the apneusis even with larger doses of morphine. 
Breckenridge and Hoff stated, "It cannot be concluded with 
certainty that this abolitaon of apneusis is a direct effect of 
morphine administration since after vagotomy in the mid-pontine 
preparation sensitivity to the cardiovascular effect of morphine is 
increased, and following all but minimal doses blood pressure falls 
precipitously and death may occur. Consequently, the disappearance of 
apneusis may 
Their method 
intravenously 
be secondary to fall 
of administration 
(causing the drops in 
in blood pressure and anoxia." 
of large doses of morphine 
blood pressure), instead of a 
constant intravenous infusion of the drug, would not allow a 
distinction between the true cause of the apneusis reversal. 
In the medullary preparation, the influence of morphine on 
respiration was almost completely overshadowed by a much more striking 
effect on circulation. The usual early stimulating effect of morphine 
on respiration, the deep sighing and post-sigh inhibition, occurred as 
in the other groups, but the time span over which these phenomena 
11 
occurred was much compressed. 
The most striking feature of all the experiments, they felt, was 
the facilitation of the deep sighing type of breathing both in the 
unanesthetized animal and after transection at all levels. This was 
suggestive of a disinhibition of lower brainstem activity by more 
rostral centers. Interpretation of their results in the intact animal 
showed morphine to produce a pattern identical to that produced by 
decet"ebration. The intact anesthetized animal showed almost 
exclusively eupneic breathing, but with rare deep breaths at random 
intervals. Decerebration or the injection of morphine instituted a 
regular rhythm of deep sighing respiration at variable rates and with 
varying amounts of post-sigb inhibition of eupnea. It was suggested 
that this type of breathing was facilitated "by pontine centers which 
were disinhibited, allowing a physiological decerebration by 
inactivating cortical and subcortical supressor mechanisms." 
According to this view, then, the respiratory depressive action of 
morphine was due to an increase in the intensity of post-sigh 
inhibition (release of the facilitory mechanism) rather than to a 
direct supressor action on eupnea itself. Left unexplained, however, 
was the primary rate-slowing action of morphine. 
Ngai (31) in 1961 re-examined the action of morphine on central 
and reflex respiratory mechanisms, expressing the results in terms of 
the organization of the central respiratory controller popular at that 
time. Morphine was administered in doses of to 2 mg/kg to 
vagotomized, midcollecular decerebrate cats, the maximal cumulative 
dose being 15 mg/kg. Though all animals showed a decrease in 
12 
respiratory frequency, the effect on tidal volume varied somewhat, 
either increasing or remaining unchanged. In some cats (n=4) the 
pontile penumotaxic center was stimulated both before and after 
morphine administration (same preparation as described above). The 
control response, consisting of respiratory acceleration, was reduced 
or abolished after 5-10 mg of morphine. Stimulation of the 
"inspiratory center" (5 cats) did not change after a dose of morphine 
from 2 to 12 mg/kg. In 3 cats, the effect of morphine on the response 
to stimulation of the medullary expiratory center was studied. With 
threshold stimuli, the response was hypernea, a response which after 
morphine required a less intense stimulus to occur. Also, the 
stimulus threshold for expirat~ry apnea appeared to be lower. 
In the last group of experiments, morphine was administered to 5 
cats in which the rostral pons had been transacted to remove the 
pneumotaxic center. Four of the 5 animals received a total dose 
ranging from 2 to 8 mg/kg, and respiration was markedly slowed. In 
the fifth cat, the respiratory rate was not changed significantly even 
after a cumulative dose of 22 mg/kg. Following the morphine, 
bilateral vagotomy in 
rate, and the tidal 
3 cats was followed by a further slowing in 
volume amplitude increased. The respiratory 
movements, however, were not gasping in character, and apneusis 
(usually observed in such preparations) did not occur. Levallorphan 
(an agent which reverses the effect of morphine), when administered to 
these animals, promptly initiated the typical apneustic pattern in 
these cats. In the other 2 cats, morphine did not prevent the onset 
of apneustic breathing following vagotomy, but levallorphan in these 
13 
cats caused the relative duration of the inspiratory phase to be 
increased. 
From the data presented, Ngai concluded morphine to act mainly in 
affecting the respiratory rate; if a decrease in respiratory amplitude 
or apnea was produced, it was transient. Also, morphine altered the 
responses to stimulation of various components of the central 
respiratory mechanism and depressed the pontile apneustic center. The 
decrease in respiratory frequency following administration of the 
morphine indicated the neural mechanism for respiratory rhythmicity to 
be depressed, demonstrated by the loss of the acceleratory response to 
stimulation of the pneumotaxic center. The hyperpneic response to 
threshold stimulation of the:medullary respiratory center also became 
reduced or absent. However, persistence of the inspiratory response 
to stimulation of the pneumotaxic center and to low frequency vagal 
stimulation (also demonstrated in this study) indicated that the 
inspiratory mechanisms were not depressed to the same extent as the 
mechanism controlling respiratory rhythm, a finding in agreement with 
the fact that morphine either increased or left unchanged the tidal 
volume. 
In the pontile decerebrate animals, the expected apneustic 
pattern did not ensue upon vagotomy after the administration of 
morphine; it was either absent, or of relatively short duration. 
Arterial pressure monitored during these experiments failed to show 
any significant decrease following administration of the morphine, 
demonstrating depression of the apneustic center was not secondary to 
hypotension. Further evidence for this conclusion rested on the 
14 
success of levallorphan in restoring a typical apneustic pattern. 
Ngai's explanation of his results were based on the assumption 
that apneusis is the manifestation of an unmodulated tonically active 
apneustic center, whose 
one of which is C0/2. 
activity depends on certain driving forces, 
In the case of morphine depression, Ngai 
hypothesized that the apneustic center was rendered unresponsive to 
C0/2, so that the prevailing driving force could not initiate or 
maintain the tonic activity of this center. Restoration of the 
responsiveness of this center, by antagonism of the morphine effects 
with levallorphan, was followed by typical apneustic breathing. 
The analysis of the respiratory action of morphine by Ngai, 
indicating that all compon~nts of the respiratory rhythm generator 
were depressed, differed from the interpretation of Breckenridge and 
Hoff (4) quoted earlier. On the basis of their published records, 
Ngai felt the effect of morphine on their midcollicular decerebrate 
dogs was in many ways similar to his own results. Those results, 
which were incompatible with Ngai's own results, were attributed to 
species differences, or different experimental techniques. 
Few studies of the respiratory actions of morphine are available 
for species smaller than the cat and dog, because of the experimental 
difficulties in measuring accurately the tidal volume and thus the 
minute volume of respiration. Conflicting studies with rats cite 
morphine as primarily depressing the minute volume, or depressing both 
rate and minute volume. A study by Kokka et al. (26) in which 5 mg of 
morphine was administered to rats, demonstrated a slight decrease in 
minute ventilation which lasted approximately 2 hours, and was due to 
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a fall in tidal volume since the rate was unchanged. Doses of 10 and 
20 mg/kg produced the greatest depression in ventilation by decreasing 
both rate and tidal volume (though tidal volume was affected to a 
greater extent). In raising the dose to levels as high as 160 mg/kg, 
the ventilation was not depressed as much as it was after 10 to 20 
mg/kg, and it was the decrease in respiratory frequency which became 
increasingly responsible for depression of minute- volume. 
Interestingly enough, measurements of oxygen consumption showed the 
greatest change after 10 to 20 mg/kg, declining to approximately 70% 
of the control level. A reversal of depression similar to that 
observed for minute volume was noted in rats receiving doses larger 
than 20 mg/kg, with 160 mg/kg increasing oxygen consumption within 60 
minutes. 
From these observations, it appeared a separation of the 
respiratory responses to morphine was exhibited with increasing doses; 
the depression of ventilation predominated at the lower doses, but was 
minimized at higher doses. Kokka cites Tatum, who remarked: " the 
stimulant action of morphine serves as an antidote to the depressant 
action." Tidal volume was depressed before rate, but this was less 
marked at higher doses while depression of frequency continued. Thus, 
the lower doses of morphine depressed ventilation primarily by an 
effect on tidal volume while the higher dose primarily affected rate. 
Depression of oxygen consumption, occurring with doses up to 70 mg/kg, 
was interpreted by Kokka to mean that depression of respiratory rate, 
usually present even at high doses, was not merely a manifestation of 
decreased metabolism. The observation that metabolic depression was 
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apparently reversed at high doses of morphine could be a 
manifestation of a central nervous system stimulant effect of the 
morphine, since tremors and convulsions were observed in some animals. 
In summary, as the morphine dose was increased (40-160 mg/kg) the 
stimulant effects of morphine antagonized some of the depressant 
effects, but depression of respiratory rate persisted even at doses 
which produced tremors and convulsions. 
The blood-brain barrier is known to impede the penetration of 
morphine into the central nervous system, yet in rats and dogs a 
significant amount of it is found in the cerebrospinal fluid (CSF). 
Florez et al. (17) addressed the question of whether the central 
effects are the same regardless of the route of entry into the central 
nervous system, or alternatively, whether different receptors are 
enganged depending on the route of entry. These investigators chose 
to study respiration after intraventricular injection of the drug, 
comparing those effects with that elicited by i.v. systemic 
administration. The study was an attempt to differentiate an action 
on the diencephalon from that on the lower brainstem by means of 
discrete injections of morphine into the third and fourth ventricles 
and the bulbar subarachnoid space. 
Experiments were performed on 30 cats anesthetized with 
Dial-urethane, and screw-type cranial cannulae were inserted 
stereotaxically for access to the third and fourth ventricle, and 
subarachnoid space. Respiration was recorded plethysmographically, 
and effects of morphine evaluated by observing steady-state 
respiration at altered levels of alveolar carbon dioxide. 
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Responses to injections of 50 ug (in 50 ul) into the fourth 
ventricle and bulbar subarachnoid space were indistinguishable from 
each other, producing a maximum decrease from control values of 
approximately 50%. Latency of onset varied between injection into the 
fourth ventricle and subarachnoid space as compared to that for i.v. 
injection, but an equivalent decrease in the frequency of respiration 
was produced after i.v. injection. 
In contrast to the reduction in frequency caused by morphine 
given systemically or by injection into the CSF in the lower 
brainstem, a similar dose injected into the third ventricle resulted 
in a prompt increase in frequency, between 125-150% over control 
values. Morphine did not deorease the tidal volume significantly when 
injected in all areas except in the third ventricle, which increased 
tidal volume substantially in the first 5 minutes, but then decreased 
below control and remained so throughout the rest of the experiment. 
The time-course of changes in end-expiratory C0/2 were consistent 
with the observed changes in ventilation. Intravenous injection of 
morphine, which produced the fastest decrease in respiratory frequency 
was responsible for the most rapid decrease in ventilation, while the 
course of C0/2 accumulation after injections into the fourth ventricle 
and subarachnoid space paralleled the gradual depression of 
ventilation. The short initial stimulation in both frequency and 
tidal volume following injection of morphine into the third ventricle 
were reflected in the reduced end-expiratory C0/2, lasting about 5 
minutes. A second phase, consisting of more shallow, but still rapid 
breathing, accounted for a sustained rise in C0/2 (consistent with the 
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decrease of tidal volume as stated above). 
The results of Florez et al. showed that restriction of 
application of the morphine to the lower brainstem produced a form of 
respiratory depression qualitatively indistinguishable from that 
obtained after i.v. injection. Conversely, application of morphine to 
the third ventricle elicited a more complicated response in which an 
excitatory ,component was evident. In addition, despite the 
similarities of the responses to systemic, fourth ventricular and 
subarachnoid space injection, the time-courses of the ensuing 
respiratory depression differed markedly. Systemic i.v. injection of 
morphine rapidly reached the whole brainstem (where the respiratory 
centers are located), and wqile the blood-brain barrier for morphine 
is pronounced, a compensation might exist by having neurons·with a 
high susceptibility to its actions. 
In agreement with previous studies, the results of Florez 
pointing to a depressed sensitivity of the central chemoreceptors to 
C0/2 "is best interpreted in terms of an elevation in the threshold of 
the respiratory chemostat or, in other words, an increase in C02 
setpoint." The respiratory response to morphine injected into the 
third ventricle however, consisted of two phases; the first, 
characterized by a brief stimulation of both frequency and tidal 
volume, suggested stimulation of receptors located in the wall of the 
third ventricle itself, or in the aqueduct. Since tremor, scratching, 
and vomiting were often observed during this time, the increased 
ventilation might be regarded as one component of a broad pattern of 
stimulation produced by actions there. The second phase, starting 
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about 10 minutes after injection and characterized by an increased 
frequency and a decreased tidal volume, had as its main consequence a 
progressive increase of end-expiratory C0/2. The reduction of tidal 
volume did not necessitate an increase in frequency, but seemed to be 
a direct effect of morphine acting either at the midbrain or brainstem 
level, where the drug was shown to reduce the tidal volume (possibly 
from the drug escaping from the third into the fourth ventricle 
subarachnoid space). These opposite effects on rate and depth would 
then be the result of the action on different sites of the central 
nervous system. 
A 1972 study by Florez et al. (16) investigated the influence of 
drugs which modify brain amine content in the morphine depressed 
decerebrate cat. In his introduction, Florez states, "Respiration is 
one of the functions more consistently depressed by morphine. In 
decerebrate cats, respiratory depression has been shown to be the 
consequence of the disturbance in the regulatory mechanisms of the 
medullo-pontine respiratory center". These remarks are reminiscent of 
the earlier, very general conclusions reached by Cushny in 1912 (7). 
However, in this particular study Florez attempted to explain the 
actions of morphine through changes in local neurotransmitter 
concentration which would influence its respiratory center activity. 
A control group of 10 decerebrate cats received 2 mg/kg of 
morphine i.v. with a similar injection following 60 minutes later. 
The injection of the first dose of morphine resulted in a prompt 
decrease of respiratory frequency, tidal volume, and minute volume. 
The maximum reduction was reached within a few minutes after 
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administration, followed by partial recovery of frequency and minute 
volume such that a steady l~vel of respiratory depression was reached 
within 15 minutes. By the end of the first hour, the minute volume 
was still reduced to 70% of the control value. Response to C0/2 
stimulus was quite diminished, accounted for by a reduction of both 
the frequency and tidal volume responses, a depression which lasted 
until the next injection. The second dose of morphine again reduced 
the resting respiratory variables, though the minimum values attained 
were no lower than those observed after the first dose. 
The respiratory action of morphine was examined in several other 
groups of decerebrate cats, which had been pre-treated with 
paragyline, tranylcypromine,;' reserpine, PCPA, a-methyltyrosine, and 
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6-hydroxydopamine. Since PCPA, a selective inhibitor -of serotonin 
synthesis, was the most consistent antagonist to the depressant action 
of morphine, Florez et al. concluded that serotonin in the brainstem 
was a synergistic factor with the action of morphine on the 
respiratory center. 
The identification of specific receptors for morphine and its 
derivatives in the mammalian central nervous system (CNS) in 1973 
(3,9,18), and the subsequent search for and discovery of endogenous 
opiatelike substances (known collectively as endorphins) in 1975 
(38,41), cast an entirely new perspective on previous research 
describing the physiological actions of morphine. Prior to this, 
morphine's various physiological effects and mechanisms of action were 
of interest because of the use of morphine clinically (and abusively). 
Discovery of the endorphins and the localization of opiate receptors 
to areas within the CNS associated with cardiovascular and respiratory 
control (20) created a fresh interest in mechanisms of action of 
opioid agents. 
Florez et al. (18) in 1977 was one of the first investigators to 
follow one of the logically suggested courses of action: since 
depression of the respiratory center was one of the most 
characteristic actions of opiates, it was pertinent to investigate the 
respiratory actions of endorphins and other endogenous opioid 
peptides. In the study mentioned previously, Florez et al. determined 
the ventral surface of the brainstem to be the most sensitive site to 
the respiratory depressant action of morphine; therefore in this 
study, using cats lightly anesthetized with a- pentobarbital-urethane 
mix (25 mg/kg and 500 mg/kg, respectively), met-enkephalin was 
injected at the ventral surface of the brainstem. Respiratory 
parameters were assessed by measuring spontaneous resting parameters 
(frequency, tidal volume, ventilation) as well as their responses to 
stimulation with 5% C0/2 in oxygen. 
Met-enkephalin, at a dose of 1.6 umole, directly applied to the 
ventral surface of the brainstem, consistently depressed respiration 
through an immediate reduction of tidal volume; frequency was less 
affected. Though the depression of minute volume began almost 
immediately following injection, 3 minutes later the depression had 
been reduced substantially, and by 15 minutes the values were similar 
to control. However, the ventilatory response to C0/2 stimulation was 
still significantly lower than the control response. At maximal 
depression, frequency was minimally affected and thereafter slightly 
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increased; end-expiratory C0/2 values remained above control for about 
15 minutes, with the low tidal volume accounting for the reduced 
ventilation. The short latency observed suggested met-enkephalin to 
be acting on ventral surface areas in the brainstem involved in 
respiratory regulation, rather than pontomedullary centers. 
Denavit-Saubie (9) conducted a more specific study, by 
investigating the effects of microelectrophoretically applied opiate 
agonists and antagonists on extracellularly recorded neurons in cat 
pontine and bulbar respiratory centers of the cat. Acknowledging the 
evidence that respiratory depression from systemic administration of 
opiates is mediated through central mechanisms, the authors pointed 
out that the direct demonstration that neurons related to respiratory 
function were sensitive to opiate administration was still lacking. 
Fifty cats were readied as "isolated respiratory center" 
preparations with bilateral vagotomy, spinal section (C7-T1), and 
immobilization with gallamine triethiodide (elimination of peripheral 
inputs to the respiratory centers). Central respiratory drive was 
monitored via a phrenic nerve recording, and respiratory neurons 
(inspiratory, expiratory, or phase-spanning) recorded extracellularly 
via multibarrelled micropipettes. The iontophoretically applied 
agonists (morphine, levorphanol, and met-enkephalin) depressed the 
spontaneous discharge of respiratory related units (RRU) by more than 
50% and suppressed the discharge evoked by short applications of 
L-glutamate in the majority of RRU's tested. In 58 RRU's tested with 
morphine, 35 were depressed; 14 showed no effect, and 9 showed 
excitatory effects. The excitatory effects became prevalent when 
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applications were repetitive at relatively short intervals (less than 
2 minutes), became more pronounced as dosages were increased, had a 
slower onset, and were generally longer lasting than the depressions. 
An unspecified number of experiments were preformed in order to 
compare the effects of systemically administered opiates, which 
influence a number of neuronal systems, to actions seen after 
localized application. Administration of morphine (0.1-0.5 mg/kg i.v. 
bolus injection) to bilaterally vagotomized, paralyzed, artificially 
ventilated cats was followed, 50-100 seconds after the beginning of 
injection, by a depression of the phrenic nerve discharge, with the 
rate of rise of discharge slowing during inspiration. The duration of 
these bursts was increased 3~-50% but the amplitude of the integrated 
inspiratory bursts decreased by 10-20%. The authors state, "Gasping 
or apneustic respiration was not seen even with rather high dosages," 
although the values these high dosages reached were never specified. 
Lastly, naloxone at dose levels where it displayed no detectable 
effect on the discharge activity on spike generation, readily 
antagonized only the depressant effect of the opiate agonists without 
affecting the excitatory action evoked in those few neurons, thus 
indicating, in the author's interpretation, that only the depressant 
actions are mediated by specific opiate receptors. 
The results demonstrated the depression of individual RRU's, 
"whose activity is probably driven by mutual re-excitatory connections 
and rhythmic inhibitory processes." The authors further explained, 
"It might be assumed that the slower rate of rise of phrenic nerve 
activity in vagotomized cats after intravenous morphine administration 
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is related to impairment of the excitatory inputs on RRU's. The 
triggering of the expiratory phase was delayed, as suggested by 
lengthening of inspiration. This might be a consequence of the 
reduced rise _of activity during inspiration rather than an effect on 
the inhibitory processes." 
Beubler (2) offered a hypothesis that the function of endogenous 
opiates would be to depress hyperactivity of biological systems whose 
functions were known to be inhibited by exogenously administered 
opiates. The endogenous opiates would form a "protective system," 
geared into activity by stimuli which were noxious at high intensity 
and which were consciously perceived; functions such as pain and 
respiration would be controll~d by the protective system. 
Since the respiratory response is a biological function inhibited 
by opiates, and in case of stimulation is enhanced by naloxone, 
Beubler investigated whether naloxone influenced basal respiratory 
minute volume and the C0/2-stimulated minute volume. In the 
urethane-anesthetized rabbit, he found the minute volume to be reduced 
by 60% with a 2 mg/kg i.v. bolus injection of morphine. This effect 
was reversed by naloxone, and in addition, transiently increased 
minute volume over control values (obtained prior to morphine) . A 5 
mg/kg i.v. dose of naloxone itself increased basal respiratory minute 
volume (an effect lasting about 5 minutes), and the minute volume 
stimulated by C0/2 also increased over that prior to the period of 
depression produced by morphine. Beubler's conclusion, therefore, was 
that endogenous opiates modulated respiration and, like exogehously 
administered opiates, reduced the sensitivity of the respiratory 
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controller to C0/2. · 
Zobrist et al. (46), in agreement with the hypothesis that 
endogenous 
regulation 
detail the 
opioid peptides 
of respiration 
effect 
might participate in or modulate normal 
within the CNS, proposed to stuqy in more 
unanesthetized rat 
of 
and 
met-enkephalin on respiratory function in the 
to correlate those effects with those of 
morphine. Two days prior to drug administration, screw type cannulas 
were stereotaxically placed in the left ventricle of rats. This 
allowed respiratory variables to be determined in the unanesthetized 
rat using whole body plethysmography. 
The onset of met-enkephalin induced respiratory depression was 
extremely rapid, with significant depression observed within 2 minutes 
following a 50 ug dose. Respiration continued to decrease, peaking at 
20-25 minutes post-drug administration and continuing past 70 minutes; 
tidal volume was more sensitive to the depressant action than 
frequency. 
respiratory 
Naloxone administered subcutaneously reversed this 
depression and was accompanied by the "overshoot" 
phenomenon in which. respiration increased above control levels, as 
noted by Beubler jn his study (2). 
The effects of met-enkephalin induced depression were seen to be 
diminished 
inhaled by 
10% C0/2. 
in a step-wise manner by increasing the C0/2 concentration 
the rats from 100% 0/2 to 95% 0/2 - 5% C0/2 to 90% 0/2 -
Minute volume progressively increased as the C0/2 
concentration was increased. This was interpreted as met-enkephalin 
altering the sensitivity to C0/2, a desensitization of the central 
chemoreceptors to C0/2. Though similar experiments using morphine 
26 
were not published in this study, Zobrist et al. concluded the 
characteristics of met-enkephalin induced respiratory depression to 
parallel that of morphine. This suggested to them, "a common 
underlying mechanism existing between met-enkephalin and 
morphine-induced al tera tiona· in respiration." 
Further support for the involvement of the opiate system in 
central respiratory chemosensitivity was presented by Pokorski et al. 
(32), who demonstrated fentanyl-depressed ventilation and 
naloxone-stimulated ventilation when the substances were applied to 
the intermediate "chemosensitive" areas of the ventrolateral medulla 
of the cat. Using 10 pentobarbital-anesthetized (30 mg/kg i.p. plus 
supplementary as required) spontaneously breathing cats, and 
monitoring the central respiratory output via a phrenic neurogram, 
pledgets of gelatin sponge soaked in the substances tested were 
topically applied to the chemosensitive caudal (1) and intermediate 
(S) areas, as well as the neighboring pyramids (non-chemosensitive). 
The remaining rostral (M) zones were not tested due to their far 
lateral localization. 
Consistent and statistically significant respiratory responses to 
fentanyl and naloxone were evoked only from the intermediate (S) 
areas. Fentanyl/ depressed the amplitude of the integrated phrenic 
activity, with an increase in frequency sometimes observed; 
naloxone-induced stimulation of ventilatory output was achieved by an 
increase in both amplitude and frequency of integrated phrenic 
activity (this activity being proportional to tidal volume and 
respiratory frequency). 
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Though the application technique might be considered somewhat 
unspecific, Pokorski et al. felt the respiratory responses they 
observed to be related to the interaction of drugs with the neural 
structures beneath the S area, although non-specific effects of the 
drug naloxone could not be excluded entirely. Concluding the 
endogenous opiates to be involved in the chemical control of 
respiration at the central level, they nonetheless could not assess 
what the contribution of this mechanism to respiratory control would 
be. 
Moss and 
respiration 
beta-endorphin, 
Scarpelli (30) assessed 
(and circulation) using 
injected ··into the 
the central depression of 
the endogenous opiate 
cerebrospinal fluid of 
pnetobarbital-anesthetized dogs. Their assessment of respiatory drive 
was by measurement of preinspiratory occlusion pressure (P500); the 
beta-endorphin effects on ventilation, its components, P500, and 
respiratory timing of unoccluded and occluded breaths were studied 
during C02 rebreathing. 
Tidal volume and P500 were depressed maximally within 15 minutes 
of an injection of 15 nmol (in 0.5 - 0.7 ml) of beta-endorphin into 
the CSF via the cisterna magna, but had recovered to control levels by 
75 minutes. At this time, minute ventilation (V) and frequency (f) 
were depressed maximally (though recovered to control by 135 minutes), 
leading to the suggestion that the decrease in f was the major 
contributor to the depression of ventilation. Analysis of the 
components of respiratory timing before and after beta-endorphin in 
both unoccluded breaths and preinspiratory occlusion showed the 
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duration of inspiration (Ti) to be shortened during the latter, with 
no significant effect on Ti in the former. In both unoccluded and 
preinspiratory occluded breaths, beta-endorphin increased the duration 
of expiration (Te) (as well as Ti) significantly, with the peak effect 
75 minutes after beta-endorphin 
hypoventilation was related to 
administration. Thus, the early 
changes in both f and tidal volume 
(V/T), whereas the later, deeper, depression of ventilation was due 
primarily to the effects on f. The effects were evident both during 
spontaneous breathing, in which end-tidal PC0/2 increased, and during 
C0/2 rebreathing in which the C0/2 threshold increased and C0/2 
sensitivity decreased. 
Pointing to the rapidity inherent in the early hypoventilation, 
Moss and Scarpelli suggested anatomically superficial endorphin 
receptors to be involved, corresponding with the C0/2 receptors 
identified by Schlaefke close to or at the surface of the medulla. The 
most superficial respiratory neurons identified are inspiratory 
neurons rostral to the· dorsal respiratory group, and Moss and 
Scarpelli (30) cite Denavit-Saubie et al. (9), whose data showed 
depression of inspiratory neurons there to be depressed by 
microelectrophoretic administration of endorphins. 
The depression of f at 75 minutes, due to prolongation of Te, 
occurred as long as there was afferent vagal activity, i.e., during 
preinspiratory occlusion (at which time phasic vagal reflexes play a 
minor role, thus reflecting minimal activity), unoccluded breathing 
(normal vagal activity) and inflation occlusion (occlusion of the 
airway at end inspiration, increasing phasic vagal reflexes, measured 
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in three experiments). In 3 dogs bilaterally vagotomized before the 
beta-endorphin administration, insignificant changes of f and Te were 
produced. The authors therefore suggested the beta-endorphin effect 
on f to be mediated by facilitation of central vagal pathways known to 
be of major importance to respiratory timing and modulated by vagal 
afferents. This possibility was consistent with their finding of the 
significant shortening of Ti by beta-endorphin during preinspiratory 
occlusion, and the delay of peak depression of f following 
beta-endorphin, since central vagal pathways are located relatively 
deeply within the brainstem. Although endorphins are generally 
regarded as having inhibitory actions, in other areas of the brain 
they have been shown to excit~,neurons directly or to activate them by 
inhibition of inhibitory interneurone. Those studies were cited by 
Moss and Scarpelli to support that either one of those mechanisms 
would be in accord with facilitation of central vagal pathways as the 
mode of beta-endorphin effect on f, although other central-timing 
mechanisms may also be involved. 
Following review of the foregoing evidence, which suggests the 
opiates to be influencing central chemoreception, a natural question 
to pursue would be possible specific effects on peripheral 
chemoreception. This line of questioning appears to be all the more 
obvious due to the discovery of enkephalin-like immunoreactivity in 
carotid body type I glomus cells, posing the possibility of an 
endogenous-opiate modulating carotid body chemoreception. 
Accordingly, Pokorski and Lahiri (33) investigated the effects of 
naloxone on the responses of the carotid body chemoreceptors to 
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hypoxia and hypercapnia in 12 anesthetized cats, 5 of which were 
anesthetized with alpha-chloralose (60 mg/kg i.p.) and 7 with 
pentobarbital sodium (30 mg/kg i.p.). Cats anesthetized with 
alpha-chloralose breathed spontaneously and were used for both carotid 
chemoreceptor and ventilatory studies, whereas cats anesthetized with 
pentobarbital were paralyzed, artificially ventilated, and used only 
for carotid chemoreceptor studies. Single or few fiber activity was 
recorded from the left carotid sinus nerve, and the ventilatory 
parameters of tidal volume, end-tidal 0/2 and C0/2 measured. 
In the protocol, the experiment started with air breathing and 
proceeded to 3 successive levels of hypoxia and finally to hyperoxia, 
during which the effects of 3-4 levels of steady-state hypercapnia 
were studied. This was done before and after an i.v. injection of 
naloxone (0.4 mg/kg). In 4 cats in which only carotid sinus nerve 
activity was measured, the effect of close intra-arterial injections 
of met-enkephalin was studied, also before and after i.v. naloxone 
administration. -rn all cats studied, significant attention was paid 
to the acid-base status of the preparation. 
Naloxone was seen to increase ventilation, thus lowering 
end-tidal C0/2; therefore, the inspired PC0/2 was raised to 
compensate. Without such adjustment, the arterial PC0/2 and H\+ 
decreased with the increase in ventilation, causing a decrease in the 
carotid chemoreceptor activity. This accounted for the finding that 
naloxone did not show a clear effect on carotid chemoreceptor 
activity. The investigators concluded from these results that 
naloxone caused a dominant ventilatory effect not mediated by the 
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peripheral chemoreceptors. 
The effects of naloxone on chemoreceptor activity, measured at 5 
different levels of arterial P0/2, showed chemoreceptor activity to 
increase hyperbolically, both before and after naloxone, with 
decreased P0/2. Ventilatory responses and arterial pH, also measured, 
showed ventilation to increase hyperbolically with the decrease of 
arterial P0/2 with and without naloxone, but arterial pH remained 
constant. The major effect of naloxone, which the authors found to be 
significant, was due to increases in V/T; the breath-frequency 
increase was small. 
The effects of naloxone on ventilation and carotid chemoreceptor 
activity at 3 different levels of arterial PC0/2 during hyperoxia 
showed chemorec~ptor discharge rates to increase with PC0/2. Naloxone 
showed no appreciable effect, but did increase ventilation at all 3 
levels. 
One example of the effects of close intra-arterial met-enkephalin 
on chemoreceptor 
Before naloxone, 
activity before and after naloxone was illustrated. 
an immediate inhibition of activity followed the 
injection, despite a decrease in systemic arterial pressure. 
Following naloxone, the chemoreceptor discharge was greater than 
control, and injection of met-enkephalin caused only a small transient 
inhibition. 
Evaluation of the relative effects of naloxone on ventilation and 
chemoreceptor activity at a given arterial P0/2 was done by plotting 
ventilation against the corresponding chemoreceptor discharge rates. 
After naloxone, the curve describing this relationship shifted upward 
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with an increased slope, indicating a central effect on ventilation. 
This supported the investigators other results, indicating the major 
ventilatory effect of naloxone was mediated by mechanisms other than 
peripheral chemoreceptors. 
Pokorski and Lahiri felt their findings to be consistent with 
other observations reported in the literature of naloxone facilitation 
of respiration. They felt their results indicated a central 
sensitization to a given carotid chemoreceptor input after naloxone. 
Also, the basic relationship between V/T and breath interval, though 
not specifically presented in the paper, was not changed by naloxone, 
indicating the pontomedullary neurons that determine respiratory 
timing mechanisms were not selectively affected. 
The stimulatory effect of naloxone on carotid chemoreceptor 
activity, apparent during hypoxia, was felt by the authors to indicate 
inhibition of activity by endogenous enkephalin, an interpretation 
supported by the observation that naloxone blocked the effect of 
injected met-enkephalin. This effect during acute hypoxia suggested 
to the authors a possible significant role of endogenous opiates 
during chronic hypoxia. Thus, the authors concluded endogenous 
opiates to be potential modulators of respiratory regulation because 
of their effects on both central mechanisms and peripheral 
chemoreceptor activity. 
B. Cardiovascular Effects of Morphine and Related Substances 
Claude Bernard in 1864 was one of the first to note the 
hypotensive action of morphine, and his results were confirmed 4 years 
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later by Gecheidlen working on rabbits and cats (see 38). The search 
for a possible mechanism for this effect has continued , complicated 
by the conflicting results obtained by different investigators in 
different species. This review will therefore, for the most part, be 
confined to that work involving cats. 
Gruber and Robinson (19), in experiments using isolated perfused 
cat hearts, noted dose-related effects of morphine when injected into 
the perfusate. In lower doses (10 mg) a marked dilation of the 
coronary vessels and a marked improvement in cardiac activity 
(increased force of contraction) was observed. A depressant action 
was seen with larger doses, "increasing the irritability of the heart" 
until fibrillation ensued • 
. Schmidt and Livingston (40) were the first investigators to 
thoroughly research the action of morphine on the mammalian 
circulation, and were the first to note that only the first i.v. 
injection of morphine in the cat and dog caused blood pressure to 
fall; upon repeated injections a steady recovery of pressure occurred. 
At this point, an i.v. injection of morphine in a dose far greater 
than that used to produce the initial hypotension would be without 
such effect, i.e., tachyphylaxis was apparent. 
In their analysis of the mechanism of this phenomena, Schmidt and 
Livingston ruled out any participation of the central nervous system 
because decerebrated cats and dogs demonstrated the same effects. 
Their experiments showed that destruction of the medulla, or that 
portion of the spinal cord posterior to it, did not prevent or 
diminish the depressor effect (provided the blood pressure was not 
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already at shock levels). They also demonstrated the entire central 
nervous system could be eliminated, but if blood pressure was 
maintained (via a continuous infusion of epinephrine), it was reduced 
by morphine just as if the animal was intact. 
Respiratory effects were also ruled out as an explanation. The 
authors observed respiration to be stimulated during the fall in blood 
pressure, and heart rate to be accelerated during the hypotensive 
period. Bradycardia appeared only during the recovery of blood 
pressure, and was maximal when pressure had returned to normal, so 
that too, was ruled out as being responsible for the acute depression. 
(This phenomenon referred to as "morphine bradycardia" is rarely 
-referenced in the earlier ;literature). From this, they concluded 
morphine to have "a depressant action upon some part of the 
cardiovascular system, wholly apart from the central regulating 
mechanisms." Further experiments in the dog showed the "vasomotor 
center" to be depressed only slightly, so that its contribution to the 
effect was small. 
Experiments utilizing isolated kidney and hindlimb preparations 
showed morphine to cause "a pure rise in perfusion pressure in the 
kidney experiments, a pure fall in that among the leg." Their 
conclusion was that morphine acted to constrict blood vessels of the 
abdominal viscera, whereas it dilated vessels in the skin and muscle. 
This was followed by bradycardia in the dog. The dilator action, 
then, was thought to be wholly peripheral, with the bradycardia being 
of central origin (larger doses of morphine producing a slight, minor 
depression of the vasomotor center). 
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Schmidt and Livingston summarized their findings:· "We conclude, 
therefore, that tolerance of the circulation is rapidly brought about 
in the normal animal poisoned with large amounts of the drug; recovery 
from the shock-like effect of the first i.v. injection or injections 
in the face of additional quantities is due to the development of this. 
tolerance. The term "acute tolerance" is suggested as descriptive of 
this condition." They went on to reject the notion that the depressor 
action might be due to liberation of a "chemical vasodilator agent" 
(such as histamine or acetylcholine), with repeated doses of morphine 
causing depletion of the tissue reserves of this agent. 
Evans, Nasmyth, and Stewart re-investigated the phenomenon in 
1952 (13). The work of Feldqerg, published just prior to theirs, was 
cited by these authors for its direct demonstration of histamine 
released in the cat following morphine administration. Feldberg had 
concluded, however, that the fall in blood pressure caused by the i.v. 
injection of morphine could not be wholly accounted for by the release 
of histamine. The purpose of Evans et al. in this study was to 
determine what other factor(s) could be responsible. 
Four different cat preparations were utilized: cats anesthetized 
with ether followed by 80 mg/kg chloralose; decerebrate cats; spinal 
cats; and anesthetized cats pre-treated with mepyramine, a histamine 
antagonist. 
In the first preparation, the anesthetized cat, an i.v. injection 
of morphine caused a biphasic response; a transient rise in blood 
pressure occurred prior to a precipitous fall 15 to 20 seconds after 
completion of the injection. Heart rate, increased slightly during 
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the first 2 to 3 minutes after the injection, was subsequently slower 
than normal, even though the blood pressure remained low for a period 
of several hours. After a second or third dose of 4 mg/kg, 
tachyphylaxis was apparent. With an i.v. dose of 20 mg/kg morphine, 
the fall in blood pressure was more profound (20-30 mm Hg), but 
recovered to 
of morphine 
control levels within 2 hours. Repetition of this dose 
also produced transient and gradually diminishing 
responses. However, respiration was always seriously compromised with 
this large of a bolus injection. 
Decerebrate cats showed similar responses to an i.v. injection of 
4 mg/kg, though 
lasted only 10-15 
the fall in blood pressure was less precipitous and 
minutes;,, tachyphylaxis was also exhibited on 
repeated injections. Evans et al. noted in these animals, the 
respiration never failed and was rarely more than very slightly 
depressed (though the cumulative dose attained was not stated). 
A 4 mg/kg i.v. dose of morphine in spinal cats caused a large 
fall in blood pressure though of lesser magnitude than in the 
anesthetized cat, presumably because the control blood pressure was 
lower in these cats. The fall in blood pressure was quite transient; 
within 70 seconds it had returned to almost control level. The 
initial pressure level was usually regained within 15 minutes, and 
with repeated doses of morphine, the fall in blood pressure was no 
longer observed. 
In the last group, the 4 mg/kg i.v. dose of morphine was preceded 
by a subcutaneous dose of 5 mg/kg mepyramine. In anesthetized cats, 
the morphine always produced a profound and prolonged fall of blood 
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pressure. In 2 decerebrate cats pre-treated with mepyramine, blood 
pressure fell but the magnitude of the response was less than half 
that normally attained in decerebrate cats. The effect in the spinal 
cat was always completely blocked by pre-treament with mepyramine. 
Atropine or bilateral vagotomy did not modify the blood pressure 
or heart rate changes. Also, because the transient rise of blood 
pressure observed in the anesthetized (but otherwise untreated) cat 
suggested that there might be a considerable release of pressor 
substances from the adrenal medulla, experiments were preformed to 
assess epinephrine levels before and after an i.v. dose of morphine. 
The content of epinephrine in adrenal venous blood samples was shown 
to be increased 10 to 15 ti~es after a dose of 4 mg/kg morphine, and 
to remain elevated for a minimum of 10 minutes. 
Comparison of the duration of the depressor response showed it to 
be similar in spinal, and decerebrate cats, but prolonged in 
anesthetized cats. This suggested to the authors that the chloralose 
either potentiated the blood pressure lowering effect of the morphine 
or inhibited compensatory mechanisms. 
Mepyramine pre-treatment did not alter the response in 
anesthetized cats, but reduced or completely abolished the response in 
spinal and decerebrate cats. The authors inferred that the phenomenon 
in the latter 2 groups was mediated by histamine released 
peripherally, and that any central actions of morphine affecting blood 
pressure were compensated by the increased adrenal secretion. The 
ineffectiveness of mepyramine in the anesthetized cat suggested 
morphine to have some central action which was potentiated either by 
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the chloralose or by vasomotor effects that were uncompensated in its 
presence. Since nei~her atropine nor bilateral vagotomy affected the 
response, it appeared morphine was affecting the "vasomotor" rather 
than "vagomotor" _center. 
Evans et al. concluded the hypotensive activity of intravenously 
injected morphine on the circulation of the cat was mediated in large 
part by an effect on the vasomotor center (i.e., removal of 
sympathetic tone) and by the peripheral release of histamine, with 
some compensation by increased secretion from the adrenal medulla. 
Contreras and Huidobro in 1970 (6) confirmed the observation of 
tachyphylaxis produced by repeated doses of morphine in the spinal 
cat, and sought to explain its cause • During the period of 
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hyposensitivity, they observed a concomitant decrease in the pressor 
response to norepinephrine. The diminution in the response was not 
due to progressive myocardial depression, because during repeated 
dosage with morphine, the characteristic signs of heart failure 
(concurrent venous hypertension and increasd left ventricular 
end-diastolic pressure) were not observed. 
The scope of this investigation was wide; the effects of repeated 
doses of morphine on a number of preparations in the spinal cat (blood 
pressure, tibialis anterior, nicotating membrane, uterus, bladder, and 
small intestine) was examined. The dose of morphine involved ranged 
from 3-36 mg/kg, and was administered "as a series of relatively 
small, but gradually increasing· doses repeated at about 5 minute 
intervals to avoid the intense hypotension, cardiac arrhythmias, and 
spinal convulsions which could be induced by single large doses." The 
authors found a parallelism between morphine tachyphylaxis and 
decreased responses to epinephrine, norepinephrine, angiotensin, 
barium chloride, acetylcholine, and 
substances to which hyposensitivity 
carbachol. The range of 
was manifest indicated to them 
that the action was either non-specific at the receptor level or 
fact that the decreased post-receptor processes. Moreover, the 
responses to the drugs occurred in all the preparations indicated some 
basic underlying process which could be related to morphine 
hyposensitivity within the central nervous system. The authors did 
admit, however, that tolerance is not shown to all the central actions 
of morphine. 
Contreras and Huidobro .. were concerned with the hypotension 
induced by morphine and the tachyphylaxis shown by this effect. 
Grundy in 1971 (20) pointed out the gradual development of 
tachyphylaxis to the pressor response as well, and attributed this to 
a continuous depletion of the adrenal medulla by the repeated 
administration of morphine, possibly in association with the 
hyposensitivity to the catecholamines Contreras and Huidobro (6) 
found. 
Only two studies prior to those of Grundy really examined the 
effect of morphine on the heart itself. The studies of Gruber and 
Robinson (19) and Schmidt and Livingston (40), both cited earlier, 
determined the dominant effect of morphine to be depressive. 
Contreras and Huidobro (6) made no mention of changes in frequency or 
force of contraction; their concern was measuring variables that would 
indicate a progressive myocardial depression was developing). 
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Grundy (20), like Gruber and Robinson, studied the effects of 
morphine in the isolated, perfused heart; however, rather than cats, 
Grundy employed guinea pigs. Morphine sometimes produced a transient 
initial stimulation when first given (lower doses), but generally it 
acted as a weak myocardial depressant, results which agreed with those 
cited previously. 
The discovery of the endogenous opiates had a tremendous impact 
on research dealing with the cardiovascular effects of morphine, just 
as it had for previous studies dealing with its respiratory effects. 
Interest in the cardiovascular effects of the endogenous opioid 
agonists generated several studies examining those effects when the 
substances were administered both centrally and peripherally. 
Florez and Mediavilla (18), cited earlier, examined both the 
respiratory and cardiovascular effects of met-enkephalin when applied 
to the ventral surface of the brainstem. Coincident with the 
respiratory effects, met-enkephalin caused a reduction in blood 
pressure and heart rate, though the intensity of the depression was 
smaller than that induced on respiration. The time course of the 
cardiovascular responses also differed slightly; the peak effect 
appeared between 1 and 2 minutes after injection and the recovery was 
more gradual and delayed, so that at 5 minutes the depression showed a 
value corresponding to more than half the peak effect (refer to the 
previous citation for time course of the respiratory effects). 
Naloxone was able to completely antagonize both the cardiovascular and 
respiratory effects. Florez concluded the met-enkephalin to be acting 
on some of the ventral surface areas in the brainstem involved in 
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cardiovascular (and respiratory) regulation. 
Feldberg and Wei (15) found morphine (400 ug) injected into the 
cerebral ventricles of chloralose-anesthetized cats produced 
tachycardia with a small, transient rise in blood pressure. The 
tachycardia still occurred after cutting the vagi, but not following 
removal of both stellate ganglia. This led to the conclusion that the 
increased cardiac rate resulted from augmented sympathetic discharge 
to the heart. The discharge was localized by the investigators to 
structures reached from the third ventricle because the strong 
tachycardia was also produced on injection of even smaller doses into 
the third ven~ricle (in such a way that little or no morphine would 
enter the lateral ventricl~), and also when the aqueduct had been 
cannulated to prevent the morphine from reaching the aqueduct and 
fourth ventricle. Morphine injection into the fourth ventricle did 
not cause tachycardia, leading the authors to believe the drug was 
acting on structures in the walls of the third ventricle (probably on 
the hypothalamus) causing an increased sympathetic discharge to the 
heart. 
Intracisternal injection of morphine (100-400 ug) produced a 
gradually developing, long-lasting fall in blood pressure and heart 
rate by acting on structures near the obex of the medulla, causing a 
reduction in sympathetic tone to blood vessels and heart and some 
increase in vagal tone to the heart. In bilaterally vagotomized cats, 
the fall in blood pressure and heart rate resulted entirely from a 
reduction in sympathetic 
cardiovascular effects of 
tone. Injected subcutaneously, the main 
morphine were found to be similar to that 
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obtained from intracisternal injections, inferring the effects to be 
of central origin. 
Morphine thus produced opposite cardiovascular effects when 
injected intraventricularly 
met-enkephalin showed this 
and intraci~ternally. 
substance to be 
Experiments with 
nearly inactive; 
tachycardia was not produced with 100-400 ug injected 
intraventricularly, and a transient hypotension was only produced when 
400 ug was administered intracisternally. Injection into the cerebral 
ventricles of 400-800 ug of beta-endorphin resulted in a tachycardia, 
but when administered intracisternally (200-400 ug) a long-lasting 
hypotension and bradycardia occurred. 
The effect seems to b~ similar to that observed when opioid 
agonists are injected intracisternally in the dog and rat, though in 
these two species the long-lasting hypotension and bradycardia is 
preceded by a transient increase in blood pressure and heart rate 
(26). To examine more precisely the central site involved in these 
effects, Laubie et al. (28) injected (d-ala/2) met-enkephalinamide (a 
synthetic pentapeptide which is much more resistant to enzymatic 
inactivation than met-enkephalin) and fentanyl (a morphine-like 
substance) into the nucleus ambiguus (NA) and nucleus tractus 
solitarius (NTS) in chloralose (100 mg/kg i.v.) anesthetized dogs. 
Microinjections of fentanyl (1 ug) unilaterally or bilaterally 
into the NTS did not change the blood pressure, heart rate, or 
splanchnic discharge. Unilateral microinjection of fentanyl ( 0.-05 - 1 
ug) into the right NA induced a dose-dependant decrease in heart rate 
without change in sympathetic discharge. The maximal effect was 
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reached after 2 minutes for 1 ug, was long-lasting, and was associated 
with a fail in blood pressure. Lower doses of fentanyl (0.05 - 0.2 
ug) decreased the heart rate but did not change blood pressure. 
Unilateral microinjection of met-enkephalinamide (0.01 to 1 ug) into 
the NA also produced a dose-dependant decrease in heart rate, but 
splanchnic discharge was unchanged and the blood pressure reduced only 
when the heart rate was markedly decreased. Intravenous injection of 
naloxone (0.1 mg/kg) antagonized the effects of both substances in all 
experiments. 
Previous work by Laubie (29) showed vagotomy to abolish the 
hypotension and bradycardia produced by morphinomimetic compounds, 
leading Laubie to conclude th&t such agents induced increases in vagal 
tone by 
14,15). 
terminals 
acting on the medulla oblongata, confirming Feldberg and Wei 
In addition, the NA was discovered to be richly innervated by 
containing enkephalin-like immunoreactivity (21). Since 
microinjection of low doses of met-enkephalinamide or fentanyl into 
the NA of dogs induced a marked bradycardia without changing either 
blood pressure or sympathetic nerve activity, Laubie concluded this 
area to be "a highly sensitive site in the production of the vagal 
bradycardia induced by narcotic analgesic agents and morphinomimetic 
peptides." 
Wallenstein (43) re-examined the biphasic cardiovascular action 
of morphine in cats in a 1979 study. A low dose of morphine (1 mg/kg) 
was administered 
pentobarbital (15-20 
nitrous oxide; all 
intravenously to cats sedated with sodium 
mg/kg i.p.), urethane (600-800 mg/kg i.p.) or 
were artificially respired. A 1 mg/kg dose 
produced a transient rise in blood pressure lasting less than 1 
minute, followed by a long-lasting decrease; no effect on heart rate 
was seen. 
In contrast, larger doses of morphine (8-12 mg/kg i.v.) produced 
an increase in blood pressure and heart rate, though in several cats 
Wallenstein noted a transient decrease to precede the increase. This 
was the result of a concurrent bradycardia, but it only occurred in 
cats receiving morphine at a rate faster than 2 mg/minute. The type 
of anesthetic used was found to have no independant effect. 
Another group of cats, adrenalectomized and anesthetized with 
pentobarbital (10 mg/kg i.p.), were also tested. A 1 mg/kg dose of 
morphine produced a decrease,.in blood pressure, but was not preceded 
by a transient increase as observe~ in non-adrenalectomized cats. The 
adrenalectomized animals were demonstrated capable of producing such a 
transient increase in blood pressure by administration of 8 ug/kg 
epinephrine in another group. Heart rate decreased, an effect not 
seen in intact cats receiving the dose. The effect on pressure and 
heart rate of the larger doses of morphine (8-12 mg/kg i.v.) was 
inconsistent in the adrenalectomized cats, again in contrast to intact 
cats. 
In agreement with the work of earlier investigators, the results 
of Wallenstein suggested low doses of morphine to induce an immediate, 
though brief, surge in catecholamine release from the adrenals which 
caused the pressor response; the following decrease in blood pressure 
and heart rate could be mediated by a decrease in sympathetic output, 
as suggested by Evans et al. (13). The fact that higher doses of 
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morphine did not produce a significant increase in the blood pressure 
or heart rate of the adrenalectomized cats suggested the adrenals to 
also have a role in the longer-lasting pressor effects usually seen 
with such doses. 
The study of Moss and Scarpelli (30), r.eferred to earlier, 
examined the effect of intracisternal injection of beta-endorphin (in 
pentobarbital-anesthetized dogs) on blood pressure and heart rate, in 
addition to the respiratory effects. In non-vagotomized dogs, both 
variables decreased progressively, reaching their lowest levels about 
105 minutes after beta-endorphin administration (30 minutes after the 
peak depressant effect on ventilation). At 135 minutes, both heart 
rate and blood pressure had increased but remained significantly lower 
than control. In vagotomized dogs, beta-endorphin lowered pressure 
significantly but produced no significant change in heart rate. In 
the intact dogs, peak depression of arterial pressure and heart rate 
occurred later than peak respiratory depression, at a time when 
respiratory variables started to increase. Also, circulation was 
depressed progressively during moderate hypoventilation (which would 
be expected to facilitate cardiovascular reflexes). From these 
results, Moss and Scarpelli concluded that beta-endorphin affected 
the circulation and respiration by separate and discrete mechanisms. 
They went on to speculate that the delay in the cardiovascular, as 
compared with the respiratory, effect may stem from sites of action 
that were relatively less accessible to beta-endorphin. Since 
vagotomy sustained the drop in pressure but eliminated the heart rate 
response to beta-endorphin, it was evident that both central vasomotor 
and vagal pathways were components of the circulatory response and 
that the opioid-induced bradycardia might involve facilitation of the 
vagal pathways. 
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CHAPTER III 
METHODS AND TECHNIQUES 
A. Introduction 
Twenty-five adult mongrel cats, of either sex, weighing 3.5 +/-
0.7 kg (mean +/- SEM), were studied in two different groups. The 
. 
first group, hereafter designated as the "Eupneic group," consisted of 
cats with midcollicular decerebration only; the second group, 
hereafter designated as the "Apneustic group," consisted of 
midcollicular decerebrate cats in which apneusis was induced by 
bilateral vagotomy and bilate~al pneumotaxic center lesion placements. 
Cats were randomly assigned to the Eupneic or Apneustic group using a 
computer generated list of random whole numbers between one and two. 
Of 25 experiments, 12 were judged successful, resulting in six cats in 
each group. Initial preparation, decerebration, and instrumentation 
as described in the following were identical for each group unless 
noted. 
B. Initial Preparation 
Cats were placed in a restraining box with only the head 
protruding. By means of a cone placed over the face, anesthesia was 
effected with 4% halothane (Fluothane, Ayerst) using a closed delivery 
system (Drager Narkovet apparatus) with oxygen as the carrier gas. 
The anesthetized cat was then placed in the supine position. A 
tracheostomy was performed and a direct connection between the 
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delivery system and tracheostomy tube established. At this time the 
halothane was reduced from its initial level of 4% to 2%. 
To record pulsatile arterial pressure, the right femoral artery 
was cannulated with PE 90 polyethelene tubing connected to a Statham 
P23Db transducer. The right femoral vein was cannulated for 
administration of supportive agents but was not utilized in any of the 
12 cats from which results are derived. The left femoral vein was 
cannulated for morphine sulfate infusion. In the Apneustic group, the 
right and left cervical vagus was isolated, and a loose moist cotton 
tie placed around each. Throughout the experiment, rectal temperature 
was monitored (Yellow Springs Instrument Co. Model 43TW 
Tale-thermometer) and maintai-ned at 37-39 degrees C by external 
heating (Gormann-Rupp Industries Model K-1-3 Water Circulator). 
C. Decerebration 
The decerebration technique is similar to that reported by 
Kirsten ( 24) • After the initial surgical preparation was completed, 
the external carotid arteries were exposed by extending the original 
midline excision (for insertion of the tracheal cannula) to visualize 
the genioglossus and styloglossus muscles. Lying between the two 
muscle bundles is the hypoglossal nerve, which was traced distally to 
the point where it crossed the external carotid artery (approximately 
em above the carotid sinus). Immediately below this crossing point 
the arteries were ligated. Since a significant portion of the 
arterial blood supply to the forebrain is derived from the external 
carotids (the internal carotid arteries of the adult cat usually are 
not patent 
circulation), 
hemorrhaging 
occlusion of 
and hence make no contribution to the cerebral 
ligation of the external carotids significantly reduces 
during the decerebration procedure (24). Furthermore, 
these vessels rather than the common carotid arteries 
maintains both carotid chemoreceptor and baroreceptor function, and 
avoids the reflex pressor response that results from common carotid 
occlusion. 
Cats were then placed in the prone position with the head firmly 
mounted in a stereotaxic frame. The head was. shaved and muscle 
cleared from the left side of the skull. Once a clean exposure was 
obtained, the head was lowered below the thorax to reduce the 
probability of inducing air ~boli through the cranial sinuses during 
the crainotomy (24). A trephine approximately 2 em in diameter was 
used to make an opening in the left parietal skull (about the size of 
a nickel). The exposed bone edges were sealed with bone wax to 
further reduce probability of air emboli. ~n incision was made in the 
dura mater and the brain tissue rostral to the mid-colliculus removed 
by vacuum suction. The basilar artery was clipped with a McKenzie 
clip and a ball of oxidized cellulose (Surgical, Johnson and Johnson) 
applied to the Circle of Willis to prevent seepage of blood. A small 
piece of Surgical was also placed on the transacted brainstem to 
minimize bleeding. 
Following completion of the decerebration, cats remained on the 
halothane-oxygen mixture for another 30 minutes. Anesthesia as 
discontinued at this time, and the cats allowed an additional 30 to 60 
minutes of stabilizing time. Twelve out of 25 decerebration attempts 
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were successful (48%) as judged by the presence of stable and 
unassisted eupnic breathing one hour after decerebration. 
D. Instrumentation 
At termination of the stabilization period, instrumentation of 
each cat proceeded. Seven channels of cardiovascular and respiratory 
data were recorded using a Grass Model 7 polygraph. All channels were 
appropriately calibrated at the start and end of each experiment. 
Pulsatile arterial pressure (monitored since the time prior to 
decerebration) was recorded with a Statham P23Dc transducer. 
Intrapleural pressure was recorded using a Statham P23Dc transducer 
and a transthoracic needle , probe inserted across the chest wall at 
about the fourth or fifth intercostal space. A heated Fleisch 
pneumotachograph and differential pressure transducer (Validyne 
MP451), connected in series with the tracheal cannula, was used to 
record inspiratory and expiratory airflows. The expiratory airflow 
signal was then integrated to give a tidal volume signal (Validyne 
FV156). Breath-to-breath oxygen (Beckman OM-11) and carbon dioxide 
(Beckman LB-1) were measured from a portion of the expired air 
constantly drawn (500 ml/minute) from a side port of the 
pneumotachograph through a heated sample inlet. 
E. Lesion Placement 
After instrumentation, a second stabilization period ensued. 
Control cats received no further interventions following completion of 
stabilization until the infusion period began. Apneustic cats 
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underwent bilateral lesion of the pneumotaxic center located in the 
rostral dorsal pons. A calibrated electrode (Kopf K1388Z) was 
stereotaxically 
Horsely-Clarke 
angle of 32 
passed through 
co-ordinates of p 
the remaining brainstem to the 
3.5, H -4.0, L 4.5 mm (37), at an 
degrees to the anterior (37), bypassing the tentorium. 
The electrode position was 
stimulation (W.P. Instruments 
functionally verified by electrical 
Series 800 Digital Stimulator; 50 Hz, 
1-2 msec, 0.5-1 mA). Lesioning was accomplished by heating the brain 
tissue to 70 degrees C for one minute with a radio frequency lesion 
generator (Radiotronics RFG 4). This procedure of stimulation/lesion 
placement was then repeated on the opposite side. 
Once bilateral pneumotaxic center lesions were placed, the right 
and left cervical vagi were cut. In successful preparations, this 
resulted in prolonged inspiratory holds characteristic of apneusis. 
F. Protocol 
In both groups, morphine sulfate was continually infused through 
the femoral vein cannula (Harvard Apparatus Co. Inc., Model 940 
Infusion/Withdrawal Pump) at the rate of 2 mg/kg/minute. This 
infusion rate was chosen on the basis of 8 preliminary experiments, 7 
of which 
"Apneustic 
(one cat) 
were performed in "Eupneic group" type cats and 1 in an 
group" type cat. An infusion rate of 0.08 mg/kg/minute 
or mg/kg/minute (one cat) resulted in prolonged 
experimental time courses lasting hours. Conversely, infusion rates 
of 3 mg/kg/minute (one cat) or 5 mg/kg/minute (two cats) resulted in 
an almost immediate severe respiratory depression, with death ensuing 
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shortly after the start of the infusion period. An infusion rate of 2 
mg/kg/minute (three cats, two "Eupneic" type, one "Apneustic type) 
resulted in a reasonable time course that allowed for different 
respiratory phases to be distinguished. The data from the three cats 
in which an infusion rate of 2 mg/kg/minute was tested is included in 
the 12 experiments judged successful. 
Morphine sulfate solutions were prepared just prior to each 
infusion by dissolving the calculated amount (in terms of salt, based 
on each particular cat weight) in 10 ml of 0.9% saline. 
Administration in the Eupneic group began a short time after the 
stabilization period ended, during which time baseline values for all 
recorded variables were ~easured. In the Apneustic group 
administration began once apneusis was seen to be definitely 
established. In both groups the morphine infusion continued until 
death of the cat. 
In Apneustic cats, the brainstem was removed and stored in 10% 
formalin for histological processing. Brainstem sections were cut at 
10 um, and every tenth section saved and contrasted with 
Kluver-Barrera stain to delineate lesion placement. Maps of lesion 
placement were constructed with the aid of a camera lucida attachment 
to the microscope at 12X magnification. 
G. Data Analysis 
The individual experimental record of each cat in the two groups 
was examined. On the basis of distinct changes in the ventilatory 
pattern throughout the period of morphine infusion, each cat was 
identified as progressing through 4 phases. In both groups, these 4 
phases, in addition to a control phase prior to the start of the 
morphine infusion, constituted the 5 phases named below. The letter 
identification indicated after each will hereafter be used for ease of 
referral. 
Eupneic Group Phases: 
P - Control 
A - Depression 
B - Periodic Breathing 
C - Recovery from Periodicity 
D - Gasping 
Apneustic Group Phases: 
P - Control 
A - Apneusis Attenuation 
B - Apneusis Recovery towards Eupnea 
C - Apneusis and Gasping 
D - Gasping 
In each cat, a representative sample (2-4 minute) of each phase 
was quantitated. Variables quantitated were: frequency (f), tidal 
volume (V/T), heart rate (HR), and mean arterial pressure (MAP, 
estimated by adding one-third of the pulse pressure to the diastolic 
pressure). Ventilation was calculated by multiplying frequency by the 
tidal volume. Though end-tidal 0/2 and C0/2 were measured, it proved 
impractical to quantitate either because: (a) calibrations were 
grossly exceeded; or (b) the gasping pattern superimposed on the 
"normal" ventilatory pattern, consisting of nearly instantaneous 
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inspirations and expirations (see following), did not allow for true 
estimations of the expired gases. Intrapleural pressure and airflow 
tracings were used as guides in the determination of respiratory 
cycles (frequency) and in delineating "normal" breaths from "gasps." 
Upon visually inspecting the record of Eupneic cats, it was 
readily apparent that a gasping pattern gradually became interspersed 
among eupneic (hereafter referred to as normal) breaths, becoming more 
dominant as the final ventilatory phase was approached. The same was 
true of the Apneustic cats, the gasps interspersing among apneustic 
breaths (an abnormal ventilation, but "normal" for this group). In 
quantitating the phases in each group, therefore, total ventilation 
(V/tot) was the sum of "nol'll1al" ventilation specific for that group 
(V/n) and gasping ventilation (V/g). V/n was calculated by 
multiplying the frequency of "normal" breaths (f/n) by the average 
tidal volume of "normal" breaths (V/Tn) measured for a representative 
phase sample. Similarly, V/g was calculated by multiplying gasping 
frequency (f/g) by the average gasping tidal volume for a 
representative phase sample. In many samples, V/Tn or V/Tg exceeded 
the channel limits, and so precise measurement was not always 
possible. The intermittant estimation of V/Tn and V/Tg thus 
introduces some error into the mean values of each for some phases in 
both groups. 
Within each group, the control period was compared to the various 
phases specific for that group by use of Dunnett's method (see 44). A 
P value of 0.05 or less was accepted as indicating a significant 
difference between the control and the phase being compared with it. 
CHAPTER IV 
RESULTS 
A. Total Cumulative Doses 
The average cumulative administered dose in the Eupneic group at 
the end of phase D was 135 +/- 28 mg/kg (mean +/- SEM). In the 
Apneustic group, the average cumulative administered dose was 166 +/-
23 mg/kg. Both values exceed the cumulative doses reported in the 
literature for bolus injection studies (see Table 2). 
B. Alterations in the Eupneio Pattern 
Figure 1 illustrates the progression of respiratory changes in a 
eupneically breathing cat during the course of the morphine infusion. 
Following a stable control phase (P) the eupneic pattern becomes 
depressed (A) almost immediately following the start of the morphine 
infusion. The appearance of a periodic pattern, resembling a 
"cluster" (or Biot) type of periodic breathing, signals the beginning 
of the next phase (B). The pattern during this phase is distinguished 
by clusters of breaths, set apart from each other by long pauses, 
which may be viewed as prolonged expiratory durations. The end of 
this longer than normal expiration is the initiation of the next 
inspiration, which then begins the next cluster of breaths. Recovery 
from this marked pattern of periodicity ensues in the next phase (C), 
during which the frequency increases to the point that distinct 
clusters of breaths no longer exist. Some gasping is seen to occur 
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Figure 1. Progression of phases in an eupneically breathing cat 
during constant morphine sulphate infusion (2 mg/kg/minute 
i.v.). Gasps are indicated by the sharp excursions in the 
intrapleural pressure and airflow tracings evident in the 
record; eupneic breaths, in contrast, produce more rounded 
. 
tracings. Ppl = intrapleural pressure; V = tracheal 
airflow, inspiration downward; V/T = expired tidal volume. 
Phases: P = control; A· = depression; B = periodic 
breathing; C = recovery from periodicity; D = gasping. 
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throughout this phase, increasing in intensity until it is obviously 
the dominant mode of respiration (D). Gasps are indicated by the 
sharp excursions in the intrapleural pressure and airflow tracings 
evident in the record; eupneic breaths, in contrast, produce a more 
rounded tracing. 
Figures 2 and 3 graphically illustrate the changes in normal 
-ventilation (V/n) and gasping ventilation (V/g), and their individual 
constituents, which occurred in the Eupneic group throughout the 5 
phases. Means and standard errors are given in Appendix A. 
In phases A and B, V/n (Fig. 2) was significantly different from 
the control phase (P) (P<0.05); phase D was also significantly 
different from control (P<0.005). The significant decrease in V/n 
(46%) during phase A from phase P was due to a nearly equal percentage 
decrease in f/n and V/Tn. The additional 9% decrease in V/n during 
phase B resulted from the continuing decrease in f/n, even though an 
increase in V/Tn occurred. During the recovery from periodicity 
(phase C), though V/Tn was still reduced from control, the major 
increase in f/n over the preceding phase (and control value) caused an 
increase in V/n. Thus, V/n during phase C was not significantly 
different from control. In phase D, V/n dropped 88% from the control 
value, again due to nearly equal decreases in f/n and V/Tn. 
Gasping (Fig. 3) was present in only 1 cat during phase P, to a 
negligible extent (thus in phase P no standard error bar is present). 
Gasping ventilation (V/g) was present to a minimal extent in all cats 
during phase A, and continues to increase in intensity throughout the 
next 3 phases. It was not until phase D, however, that V/g and its 
59 
Figure 2. Alterations in normal ventilation and its components 
during progression of phases in the Eupneic group. Values 
are mean + SEM (n=6). Phases: P = control; A= initial 
depression; B = periodic breathing; C = recovery from 
periodicity; D gasping. * = P<0.05; *** = P <0.005 as 
compared to control (Dunnett's test). 
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Figure 3. 
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Development of gasping during progression of phases in the 
Eupneic group. Values are mean + SEM (n=6). Gasping was 
present in only cat during phase P to a negligible 
extent (thus no standard error bar is present). Phases: 
P = control; A = depression; B = periodic breathing; C = 
recovery from periodicity; D = gasping. *** = P<0.005 as 
compared to control (Dunnett's test). 
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constituents V/Tg and f/g differ significantly from phase P values· 
(P<0.005). 
V/tot was significantly different from control during phase B 
only (P<0.05) (see Fig. 10 and Appendix A). Though V/n was depressed 
to almost half the value it was in A, V/g was increased several 
thousand times; thus, V/tot is decreased during phase A because of the 
large increase in V/g. During phase B, V/n decreases further; V/g 
also decreases, but remains tremendously elevated above control 
levels. 
During the recovery from periodicity (phase C), V/tot increases 
towards the control value, due in part to the increase in V/n. Though 
still depressed by 
actually increases 
1 6% when compared to 
by 46% over its phase 
the control value, V/n 
B value. V/g begins a 
gradual rise during this phase, a rise which culminates during phase D 
when it was nearly one hundred thousand times the control value. 
V/tot was decreased from the control value by only 30% during phase D, 
which was a moderate depression considering that during phase A it had 
been reduced by nearly half. This was due to the aforementioned 
increase in V/g, since V/n during this phase was decreased by 88% from 
its control value. 
Figure 4 shows the variations in heart rate (HR) and mean 
arterial pressure (MAP) in the Eupneic group. HR decreases slightly 
during A, and changes throughout the rest of the phases were minimal. 
Thus, HR did not at any time differ significantly from the control 
value. MAP increased slightly during phase A, a change that was not 
significant. During phase B, MAP fell rapidly below control levels (a 
Figure 4. 
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Variations in heart rate and mean arterial pressure during 
progression of phases in the Eupneic group. Values are 
mean + SEM (n=4 and n~6 respectively). The morphine 
tolerance effect noted by Schmidt and Livingston (40) and 
Evans et al. (13) was not apparent, since arterial 
pressure continued to decrease over the course of the 
infusion. Phases: P = control; A = depression; B = 
periodic breathing; C = recovery from periodicity; D = 
gasping. * = P<0.05; ** = P<0.01; *** = P<0.005 as 
compared to controls (Dunnett's test). 
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decrease of 29%), a difference that was significant when compared to 
control (P<0.05). MAP was also significantly different from control 
during phases C and D (P<0.01 and P<0.005, respectively), falling 39% 
from control during phase C and 45% during phase D. 
c. Alterations in the Apneustic Pattern 
The 6 cats comprising this group were all in a functional 
apneustic pattern prior to the start of the morphine infusion. Upon 
histological examination of the lesion placement, 2 cats were found to 
have unilateral, rather than bilateral, pneumotaxic center lesions. 
In both cats, however, apneusis resulted when the vagi were cut, and 
the data from these experiments was similar to the 4 cats with 
bilateral lesion placement. Therefore, these 2 cats were included in 
the final data analysis. Figure 5 shows a typical brainstem 
demonstrating histologically verifiable bilateral pneumotaxic center 
lesions. 
Figure 6 illustrates the progression of respiratory changes in an 
apneustically breathing cat during the course of the morphine 
infusion. Prior to the start of the infusion, severely prolonged 
inspiratory holds that are definitive of apneusis are clearly present 
(phase P). At the start of the infusion, an immediate effect observed 
was a shortening of the apneustic hold such that the apneustic rhythm 
was accelerated, i.e., frequency increased (more apneustic breaths, of 
shorter duration, per minute). Thus, the apneusis was attenuated 
(phase A). In 2 unsuccessful experiments, where apneusis was allowed 
to continue for some time before beginning the infusion, the cats 
67 
Figure 5. Destruction borders of lesion placements in the 
pneumotaxic center of the rostral pons. The stereotaxic 
.coordinates were: posterior (P) 3.5 mm, vertical (H) -4.0 
mm, and lateral (L) 4.5 mm. This frontal plane section 
was drawn with a camera lucida attachment to a microscope 
at 12x magnification. Bilateral lesion sites are 
indicated by the shaded areas. NPBM = nucleus 
parabrachiolis medials; KF = Kolliker-Fuse nucleus; BC = 
brachium conjunctivum; BP = brachium pontis • 
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Progression of phases in an apneustically breathing cat 
during constant morphine sulphate infusion (2 mg/kg/minute 
i.v.). The start of the inspiratory phase begins with the 
downstroke of the pen, and terminates at the upstroke. In 
panel P, therefore, only one complete inspiratory phase is 
shown, which is definitive of the prolonged holds of 
apneusis. Ppl = intrapleural pressure; V = tracheal 
airflow, inspiratin downward; V/T = expired tidal volume. 
Phases: P =control (apneusis); A= apneusis attenuation; 
B = apneusis recovery towards eupnea; C = apneusis and 
gasping; D = gasp*ng. 
Q 
~==-=-:::::'k:::~~ 
a. ~:@4 
=
-1 
=i~ 
-:J 
71 
died. Consequently, in 4 out of the 6 successful experiments the 
infusion was begun almost immediately after apneusis was seen to be 
established. 
T~rough phase B, the apneusis was diminished. Though inspiratory 
holds are still present, they are of shortened duration and intensity. 
The apneustic tendancy continues through phase C, but gasping 
noticeably appears and is intermixed among the apneustic breaths. 
During phase D, the apneustic pattern was no longer dominant; instead, 
as in the Eupneic group, gasping has become quite prominant, and can 
be viewed as being superimposed on the "normal" apneustic rhythm in 
these cats. 
Figure 7 illustrates graphically the changes in f/n, V/Tn, and 
V/n for the Apneutic group. The "normal" pattern referred to in these 
cats is the apneustic pattern seen before the start of the infusion. 
During phase P, f/n was minimal, or, in other words, the inspiratory 
hold was so prolonged that there are nearly zero complete respiratory 
cycles per minute. 
together with the 
apneustic pattern. 
V/Tn during phase P was extremely high; this, 
decreased frequency, constituted a characteristic 
During apneusis attenuation (phase A) f/n was 
increased, though not significantly, thus accounting for the increase 
in V/n seen at this time. V/Tn was minimally affected in this phase. 
By phase B, f/n increased significantly over the control value (a 
300% increase, P<0.05), while V/Tn decreased slightly but not 
significantly. V/n was significantly increased over the control phase 
(P<0.005) because of the increase in f/n, reaching its maximum value 
this phase. V/Tn continued to decrease through the next phase, a 
72 
Figure 7. Alterations in normal ventilation and its components 
during progression of phases in the Apneustic group. 
Values are mean + SEM (n=6). The norma+ pattern referred 
to in these cats is the apneustic pattern seen before the 
start of the infusion. During phase P, the inspiratory 
holds are so prolonged that there are nearly zero complete 
respiratory 
(apneusis); 
cycles 
A = 
per ·minute. Phases: 
apneusis attenuation; 
p = control 
B = apneusis 
rrecovery towards eupnea; C = apneusis and gasping; D = 
gasping. * = P<0.05; ** = P<0.01; *** = P<0.005 as 
compared to control (Dunnett's test). 
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significant drop (P<0.05) of 49% from control. However, f/n continued 
to increase significantly over control (P<0.005). The large decrease 
in V/Tn during 
decrease in .V /n, 
level but lower 
this phase is the primary factor determining the 
such that it was still elevated from its control 
than phase B. During the gasping phase D, V/n was. 
lower than it was during phase P by 60%; f/n was nearly returned to 
control level, and V/Tn was reduced significantly (P<0.005) even more 
from the initially elevated value. 
Figure 8 presents the changes in f/g, V/Tg, and V/g throughout 
the phases. Gasping gradually increases as the infusion progresses, 
reaching its peak during phase D. The increase in f/g and V/Tg over 
control becomes significant during phase C (P<0.05), but V/g becomes 
significantly different from control (P<0.005) during phase D. By the 
final phase, f/g increased 279% over control while V/Tg had increased 
650%; the increase in V/Tg, thus, accounted for the rise in V/g this 
phase. 
V/tot differs from control during all phases. The increase in 
V/tot during phase A is primarily due to the 500% increase in V/g over 
control. In contrast, the increase in V/n accounts for the increase 
in V/tot during phase B. The continuing increase in V/g predominates 
during phase C, causing V/tot to rise further. V/tot peaks in the 
last phase, coinciding with the large increase in V/g over control 
levels which overcomes the large decrease in V/n. 
Figure 9 shows that heart rate was unchanged throughout the 
majority of the experiment (as in the Eupneic group), though by phase 
D it had decreased significantly from the control value (P<0.01). 
r 
Figure 8. 
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Development of gasping du;ing progression of phases in the 
Apneustic group. Values are mean + SEM (n•6). Gasping 
gradually incre~ses as the infusion progresses, reaching 
its peak during phase D. Phases: P • control (apneusis); 
A = apneusis attenuation; B = apneusis recovery toward 
eupnea; C = apneusis and gasping; D = gasping. * = 
P<0.05; *** = P<0.005 as compared to control (Dunnett's 
test). 
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Figure 9. Variations in heart rate and mean arterial pressure during 
progression of phases in the Apneustic group. Values are 
mean + SEM (n=3 and n=6 respectively). Heart rate was 
unchanged throughout the majority of the experiment, 
though by phase D it had decreased significantly from the 
control value (p<0.01). The high rates probably reflect 
the hypoventilation (relative to a normal ventilation) 
that existed throughout the course of the infusion. The 
decrease in rate is in agreement with the literature and 
may be a reflection of a direct depressant effect of 
morphine. Mea~ arterial pressure, which was quite 
elevated during phase P, decreased steadily (to a 
significant extent) throughout the remaining 4 phases. As 
in the Eupneic group, the morphine tolerance effect was 
not apparent. Phases: P = control (apneusis); A= 
apneusis 
eupnea; 
P<0.01; 
test). 
attenuation; B = apneusis recovery towards 
C = apneusis and gasping; D = gasping. ** = 
*** = P<0.005 as compared to control (Dunnett's 
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Mean arterial pressure, quite elevated during the control phase, 
decreased steadily (to a significant extent) throughout the remaining 
4 phases. 
D. V/g as an Increasing Component of V/n 
Table I details the per cent contribution of V/n and V/g to V/tot 
as the phases progress in both the Eupneic and Apneustic group. It is 
evident in both groups that as the cumulative dose of morphine 
• • increases, the contribution of V/g to V/tot increases, while that of 
V/n decreases. 
Figure 10 is a graphic summary of these changes in non-gasping 
ventilation (V/n), gasping ventilation (V/g), and total ventilation 
(V/tot). Before the start of the morphine infusion, only cat among 
those respiring eupneically had any gasping present. In contrast, 
gasping was present in 3 out of 6 cats in the Apneustic group. Since 
total ventilation at this time was minimal in these cats, a probable 
cause of the gasping was hypoxia. Gasping gradually became 
superimposed on the normal ventilatory pattern, eupnea or apneusis, as 
each became depressed. The depression of the normal pattern was quite 
obvious for the Eupneic group, but depression of the normal pattern in 
the Apneustic group (that is, apneusis) was more subtle. It was 
reflected as an increase in non-gasping ventilation, since as apneusis 
was decreased, the pattern resembled a more eupneic-like type of 
respiration. In phases C and D, however, the non-gasping ventilation 
was decreased, reflecting a return of apneusis. Figure 11 shows 
experimental records from cats in both groups. As shown in Figure 10, 
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Table 1 
Percent contribution of normal breathing and gasping to total 
ventilation in the Eupneic and Apneustic groups. 
Group 
Phase 
p 
V/n Eupneic 100.0% 
Apneustic 68.2% 
V/g Eupneic Neglig. 
Apneustic 31.8 
Phase 
A 
90.2% 
51.5% 
9.8% 
48.5% 
Phase 
B 
91.6% 
65.5% 
8.4% 
34.5% 
Phase 
c 
89.1% 
39.9% 
10.9% 
60.1% 
Phase 
D 
17.2% 
5-5% 
83.2% 
94-5% 
The normal (V/n) and gasping (V/g) ventilation values are normalized 
from mean values given in Appendix A. The contribution of gasping to 
total ventilation is maximal for both groups during phase D, when the 
cumulative dose of morphine sulfate is also maximal. See text for 
definition of phases (page 54). 
81 
Figure 10. Comparison of total ventilation, normal ventilation, and 
gasping ventilation during the progression of phases in 
both the Eupneic and Apneustic groups. Values are mean + 
SEM (n=6 for each group). See text for discussion. 
Phases for the Eupneic group as in Figure 1 , and for the 
Apneustic group as in Figure 6. Graphs of normal and 
gasping ventilation are composites of Figures 2~ 3, 7, and 
8. Statistical comparisons were made only within groups, 
not between groups. * = P<0.05; ** = P<0.01; *** = 
P<0.005. (Dunnett's test). 
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Figure 11. Superimposition of gasps on eupneic or apneustic breaths. 
The experimental tracings illustrate the combination of 
eupnea and gasping (left), and apneusis and gasping 
(right), occurring during phase C for both groups. Ppl = 
. 
intrapleural pressure; V = tracheal airflow, inspiration 
downward; V/T = expired tidal volume. 
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the increase in gasping ventilation as the phases progress was similar 
for both groups. ~ Likewise, as seen in Figure 11, imposition of 
gasping upon the normal pattern was similar in both groups, although 
their normal patterns are so dissimilar. The gasps occurring during 
the apneustic holds are especially intriguing, because the two types 
of ventilation are at opposite ends of the spectrum as regards 
respiratory timing. Gasps, regarded as having almost instantaneous 
inspiratory durations (Ti times), were superimposed on inspiratory 
holds of much longer duration. Thus, two distinctly separate types of 
pattern generation were occurring simultaneously. 
CHAPTER V 
DISCUSSION 
In a recent study, Hug et al. (22) concluded it is not possible 
to relate any specific concentration of morphine in the plasma or 
cerebrospinal fluid to a given intensity of ventilatory depression. 
Their studies demonstrated changes in morphine levels in plasma do not 
indicate proportional changes in its concentration in the central 
nervous system, the site of morphine's respiratory actions. For this 
reason, measurement of plasma levels of morphine was not performed in 
this study. Consequently, no attempt is made to correlate a specific 
dose level with an observed effect. 
A. Literature Summary 
1. Respiratory Effects of Morphine and Related Substances 
Earlier studies dealing with morphine and its effects on 
ventilation are difficult to assess largely due to their ancedotal 
nature. Often, the number of animals and morphine dosages (per body 
weight) were not indicated (7,39). The type of anesthetic (and dose) 
used for a particular experiment reported was not always clear. 
Measurements of ventilation, tidal volume and frequency were crude, 
and averaging of results and statistical comparisons not done. 
Beginning with the study of Dripps and Dumke (11), the papers 
reviewed start 
observational. 
to become somewhat more quantitative than 
The number of animals used for each procedure was 
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noted, dosages were expressed in terms of body weight, and the 
possible influence of the anesthetic used considered. The data 
presented was normalized and, at times ancedotal in nature, and the 
overall presentation had a "semi-qualitative" approach. This was 
evident in the work of Breckenridge and Hoff (4) and Ngai (31). 
Of the papers cited, Kokka in 1965 (26) represented the first 
quantitative presentation of the type which has come to be expected in 
the literature today. Measurements of ventilatory parameters were 
more sophisticated, and data were averaged and statistically 
evaluated. However, with the emergence of more technically intricate 
experiments (such as the microinjection of opioid agonists into 
discrete areas of the brain, and microelectrophoretic application of 
agonists to ~xtracelluarly recorded neurons), the presentation of data 
again, at times, bordered on the ancedotal. Though technically 
sophisticated, upon reflection, experiments of this type are 
inherently crude, for the investigator is unable to determine 
accurately the concentration of the compound at the neuronal surface. 
The question then arises as to whether or not physiological doses of 
agonists - or antagonists - are being examined. 
Though the major weakness of the earlier studies was the 
presentation of data in a descriptive manner, that is also their 
major strength. Ending with Ngai's study (31) in 1960, most of the 
papers reviewed present pages of actual experimental records, and 
detailed observations made during the course of the experiments. The 
concept of the organization of the respiratory controller used in 
interpretation of the results is presently different from that in 
88 
89 
earlier studies. However, the presence of these original records 
allows the earlier studies to remain instructive. 
One problem common to all studies is the superposition of the 
depressor effects of opiate agonists upon anesthesia. Unanesthetized 
freely-moving animals, however, present a whole different set of 
problema, especially since the opiates are known to be influential in 
a variety of behavioral activities. Though not without its own 
problems, the use of . the decerebrated animal largely avoids the 
problems associated with anesthesia. The complicating effects of 
anesthetics are seen in a study by Urea and Liebeskind (see 25). 
Morphine had an inhibitory effect on periaqueductal neurons in 
anesthetized animals, but· an excitatory effect in unanesthetized 
animals. 
A possible complication in many of the whole animal studies 
dealing with opioids is the common method of administration: bolus 
injection. Agents administered in this way can cause an initial 
respiratory and circulatory depression so severe (depending on the 
dose), that the physiological state of the preparation may be 
compromised throughout the remainder of the experiment. The same dose 
given in repetitive, small bolus injections may have different effects 
than when administered as one bolus (6). 
Lastly, in assessing the respiratory effects of morphine and the 
endogenous opiates, few of the recent papers presented recognize the 
fact that a number of different kinds of receptors for these 
substances exist. Two classes of opiate receptors shown to exist are: 
(a) the ,, ,, mu receptors, or morphine receptors, which preferentially 
bind morphine and the 
enkephalin receptors, 
Thus, if enkephalins 
endorphins; and (b) the sigma receptors, or 
which preferentially bind enkephalins (41). 
(or their analogs) are used in one experiment, 
it may not be possible to extend the conclusions from such a study to 
encompass the effects of all opioid substances. The hope that 
Oorphine itself could give insight into the role of all endogenous 
opiates in respiratory control may, therefore, not be entirely 
fulfilled. Also, multiple forms of opiate receptors,require different 
concentrations of naloxone to antagonize effects mediated by these 
receptors. Many recent investigators assume the effects of naloxone 
are due to blockade of the receptor, but there have been reports which 
indicate that naloxone may ~ave pharmacological actions unrelated to 
opiate receptor blockade. This observation emphasizes that antagonism 
by naloxone is a necessary, but not sufficient, criterion for 
invoking the mediation of a response by an endogenous opiate (a fact 
too often ignored by investigators in drawing conclusions from studies 
utilizing naloxone) (38). 
Since the publication of Krueger et al. in 1941 (27) and Reynolds 
and Randall in 1957 (34), it has been accepted in the literature that 
the effects of morphine on respiration are very much dependant upon 
the species studied and the experimental conditions under which the 
study is conducted. A summary of the literature reviewed in the 
literature section, part A, is presented in Table 2. In general, 
the predominant effect in a given species depends upon the dose and 
the resistance of respiratory (and cardiovascular) centers to 
depression. Upon closer examination, however, similarities do exist. 
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Table 2 
Summary of the literature reviewed dealing with the effects of 
morphine and related substances on the respiratory system. The 
following abbreviations are used in this table: 
BE beta-endorphin MI microinjection 
c cat MPK mg/kg 
D dog NE no effect 
E ether RT rat 
F fentanyl s species 
f frequency SAS subarachnoid space 
• IC intracisternal sc subcutaneous 
IM intramuscular SMLD small dose 
IV intravenous Ti inspiratory duration 
IVT intraventricular Te expiratory duration 
LRGD large dose u urethane 
. 
MCD maximum cumulative dose v ventilation 
V/T tidal volume 
Route of 
Investigator s Anesthesia Drug Admin. 
Wood M 
& D ? LRGD IV 
Cerna 
M 
1892 ? cum. IV 
dose 
Filehne M 
1879 R ? IV 
M 
DC 1-2 IV 
MPK 
R 
Cushny M 
1913 DC 1-2 IV 
vagot. MPK 
M 
c DC 1-2 IV 
MPK 
Barbour E M 
1914 c vagot. 10 IV 
MPK 
Jackson E, then M 
1914 D pithed LRGD IV 
Effects on Effects on 
f VT 
? ? 
t t 
slowed first 
• +-convulsion ? 
t but not 
t to same ex-
tent as f 
t but not 
t to same ex-
tent as f 
t but not 
t to same ex-
tent as f 
may or may 
t not t 
? ? 
Overall Effect Effect on 
on V sponse to 
near cessation 
t 
convulsions 
slowed, then t 
during 
convulsions 
reduced depressed 
reduced depressed 
reduced, more 
strongly than 
in rabbit 
periodic charac-
ter which may not 
appear w/repeated 
doses 
constriction of 
bronchiolar muscle 
periodic respir. 
w/repeated doses 
Re-
C02 
\0 
N 
Route of Effects on 
Investigator s Anesthesia Drug Admin. f 
M 
Cushny R u 3 MPK IV i 
& 
Lieb 
1914 M 
c DC LRGD IV t 
M 
SMLD IV i 
. M 
DC 1-5 IV or + 
Schmidt MPK IM 
& DC M apneustic 
Harer c vagot. 1-5 IV or tendancy 
1922 MPK IM 
DC M sue. 
vagot.& doses IV or 5-10 IM t 
non-vago t . MPK 
Dripps & M 
Dumke D DC MCD IM ? 
1943 c 16 MPK 
Breckenridge Unanesth. M IV slight, 
& D + Hoff 
1952 
I Effects on Overall Effect 
. 
VT on V 
-1-, but blood C02 
? unchanged until f v~ry depressed 
t; convulsions 
? present 
? i 
t + 
Expiration active 
? rather than 
passive 
Expiration active 
w/LRGD's; 
? convulsions 
? depressed 
slight tachypnea prior 
+ to depression; 
post-sigh 
I inhibition 
Effect on Re-
sponse to C02 
-
depressed 
depressed 
After 60 mg 
f t in re-
sponse to C02 
depressed 
but to a > 
extent in C 
t;han D 
1.0 
w 
!Route of Effects on Effects on Overall.Effect Effect pm Re-
Investigator s Anesthesia Drug Admin. f VT on V spouse to C02 
post-sigh inhibi-
DC tion; depression 
Breckenridge non-vagot. M IV + +_ stronger than in 
& D unanesthetized do~ 
Hoff DC t acceleration of 
1952 (apneustic) M IV <+ in TI) ? apneustic rhythm 
(cont'd.) DC short period of 
upper med. M IV + + tachypnea,followed 
sec,; vagot by si~hing rhythm 
DC M 1-2 IV + t orNE + 
Ngai c vagot. MPK 
1961 DC (15 
rost. pons MPK IV + t apneusis and gasp-
sec.; vagot MCD) ing not observed 
M 
Kokka 5 MPK IV NE + + 
et al. R Unanesth. M + but to > 
1965 10MPK IV + extent than + T 20MPK f 
M +-as dose t, +, but < not as depressed 
720 IV this caused marked than as with 10-20 
. 
MPK + v @ lower MPK 
dose 
Florez Dial-U M IVT-4th 
et al. c 0.7 ml/kg, 50]lgl ventricle· + NE + depressed 
1968 IP 50 ].11 SAS 
Route of 
Investigator s Anesthesia Drug Admin. 
Florez Dial-U M 
0.7 ml/kg 50}lgl IV 
et al. c 
1968 IP 50 Jll IVT 
(cont'd.) 3rd 
M 
Florez c DC 2 MPK IV 
et al. M 2 MPK IV 1972 4 MPK 
MCD 
Florez PB-U ME MI 
& c (25 MPK- 1.6 vent. 
Mediavilla 500 MPK) ]lmole surface 
1977 brainstem 
Denavit- isolated phoretical-
resp.ctr. M ,ly applied 
Saubie .. to RRU's prep. 
et al. c 
I 
isolated M 
1978 resp.ctr. 0.1- IV 
prep; 0.5 
paralyzed MPK 
Beubler u M 
1980 R 1.4 g/kg 2 MPK IV 
IP 
I 
Effects on Effects on 
f VT 
+= to injec. 
into 4th NE 
vent.or SAS 
t ls_t 5 min, 
t then + below 
control 
+ + 
+ but mini- + but mini-
mum values mum values 
not < than not < than 
aft.1st dose aft.1st dose 
less 
affected 
than VT + 
- -
+ (measured t (measured 
by phrenic by phrenic 
nerve dis- nerve dis-
charge) charge) 
+ t 
Overall.Effect Effect on Re-
on V sponse to C02 
+ = + from 4th 
vent. and sub- depressed 
arch. space 
imprc;>Ved f 
+ response 
+ depressed 
+ 
depressed 
+ for very depressed 
short duration remained so 
- v t 
majority of RRU's 
depressed; some 
excited 
Gasping or apneu-
sis not observed 
+ depressed 
& 
I 1.0 \.11 
Route of Effects on Effects on Overall.Effect Effect on Re-
Investigator s Anesthesia Drug Admin. f VT on V sponse to C02 
Zobrist t but to 
et al. R Unanesth. ME IVT t > extent t 
1981 T 50lJ.g than f 
Pokorski PB topical s - NE s - t 
et al. c 30 F applica- -
1981 IP tion to L - NE L - NE 
L&S areas 
PB BE max. t t max. w/in max. depression 15 IC @ 75 min. 15 min; re- @ 75 min (+ in depressed Moss 25 MPK nmol. t in TE covered by f major contri-& D 75 min. butor) Scarpelli 
1981 PB BE 
25 MPK 15 IC insignif. t t 
vagot. nmol. change 
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Almost unequivically, the respiratory response to C0/2 is reduced. 
Also, smaller doses of morphine produce different effects than larger 
doses. In both the dog and cat, there is evidence that morphine can 
alter apneusis to some extent. The acceptance of morphine as a 
respiratory depressant masks the complexity of the morphine action 
pattern that is evident in the literature. 
2. Cardiovascular Effects of Morphine and Related Substances 
Much of the foregoing discussion concerning the effects of 
previous studies dealing with the respiratory effects of opiates apply 
when assessing studies dealing with cardiovascular effects, and will 
therefore not be reiterated here. However, an additional factor not 
yet considered is the degree of interaction between the respiratory 
and cardiovascular systems, that is, to what degree will the response 
of one system to an opiate affect the response of the second system. 
Concern about system interactions have been minimal. The 
separation of both literature and discussion into respiratory and 
cardiovascular effects of morphine and related substances is 
admittedly artificial, but it is a division which has persisted in the 
literature. For example, of the literature reviewed in this thesis, 
few investigators (18,30) examined both respiratory as well as 
cardiovascular effects of the opioids in any detail. Partly to blame 
for this existing separation is the relative lack of quantitative 
knowledge concerning the amounts of interaction occurring between the 
two systems, thus allowing only for a qualitative estimation. 
In this study, significant detail has been paid to both the 
respiratory and cardiovascular changes occurring over the course of 
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the constant i.v. infusion of morphine, though the primary focus has 
been on alterations of respiratory patterns. Some of these 
alterations that were observed in this study, however, may be the 
direct result of morphine's action(s) on the cardiovascular system 
(see following discussion). Therefore, although this interaction 
between the two systems has yet to be quantitated, it may be a key 
consideration when explaining the actions of morphine on the 
cardiopulmonary system as a whole. 
Table 3 is a summary of the related cardiovascular literature 
reviewed in Literature, part B. Generally, morphine and related 
substances appear to cause some degree of hypotension (sometimes in 
the cat preceded by a transient rise in blood pressure). The effects 
. 
on heart rate have not been as well characterized, and it appears that 
they may depend on the route of administration. In contrast to the 
microinjection studies dealing with the respiratory effects of 
centrally administered opiates, interest has begun to focus on more 
discrete areas in the brainstem that may be mediating the 
cardiovascular effects of these substances. It may be that 
localization of these areas will precede that of the areas mediating 
respiratory effects, because of the diffuse nature of the respiratory 
controller network. 
B. Alterations of Respiratory and Cardiovascular Variables in 
Eupneically Breathing Cats 
1. Morphine effects on breathing frequency and tidal volume 
The specific effects on morphine on f and V/T are not clear, 
Table 3 
Summary of the literature reviewed dealing with the effects of 
morphine and related substances on the cardiovascular system. The 
following abbreviations are used in this table: 
BE beta-endorphin MI microinjection 
BP blood pressure ME met-enkephalin 
c cat MEA met-enkephalinamide 
CL chloralose MPK mg/kg 
D dog NE no effect 
DA direct application; PB pentobarbital 
DC decerebrate PIP perfusate-isolated 
preparation 
DD dose-dependant RI results inconsistent 
F fentanyl s species 
GP guinea pig sc subcutaneous 
IC intracisternal SP spinal 
IV intravenous trans. transient 
IVT intraventricular u urethane 
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Route of 
Investigator s Anesthesia Drug Admin. 
Gruber & M 
Robinson c - low & PIP 
1929 high 
dose 
Schmidt i M & I DC, SP' u 
Livingston D 1 ether 0.5 & IV 
1933 c i phenobarb. 1-2 
I MPK 
CL-80 MPK 
Evans, atropine M 
Nasmyth, c vagoto- 4 MPK IV 
& Stewart mized 
1952 DC M 
4 MPK I IV 
SP M I 
4 MPK I I IV 
CL-80 MPK M I 
mepyramine 4 MPK IV 
DC M 
4 MPK IV 
SP & M 
mepyramine 4 MPK IV 
Effects on the 
Heart 
low dose - t 
force of contrac-
tion high - + 
? 
t rate w/in 
2-3 min, then 
+ lasting 
several hours 
? 
? 
? 
? 
• 
? 
Effects on 
BP 
. 
-
+ 
both doses 
trans t, 
then + 
lasting several 
hotirs 
+ 
+ 
+ 
+ 
NE 
Other I 
Observations 
Fall in BP, last-
ing 10-15 min 
+ of lesser magni 
tude and trans. 
+ in BP profound 
& prolonged 
+ in BP < than ~ 
normally attained 
f-' 
0 
0 
Route of Effects on the Effects on Other 
Investigator s Anesthesia Drug Admin. Heart BP Observations 
Grundy trans. 
1971 CP - M PIP initial stim -
Florez PB 25 MPK ME DA, ventral 
1979 c u 500 MPK 1.6 surface of + + 
. llmole brainstem 
MEA MI into 
0.01- NA + - DD + when HR is unilateral 
Laubie CL 1 llg markedly + iniection 
1979 D 100 MPK F MI into .~ '\ ~ unilateral & hi-
1 llg NTS NE NE lateral injection 
F MI into unilateral injec-
0.05- NA + - DD + tion; no change 
1 llg in symp discharge 
F MI into 
0.05- NA + NE 
0.2 1-lg 
PB 15-20 M 
MPK;u 600- 1 MPK IV NE long-lasting + + before trans.t 
Wallenstein 800 MPK; • 
1979 c nitrous M 
oxide 8-12 IV t t + HR, + BP 
llg/kg before t 
PB 10 MPK M-1 
adrenalect. llg/kg IV + + no trans.t 
preceding+ 
I 
Investigator s I Anesthesia Drug I 
Wallenstein PB 10 MPK M-1 
1979 c adrenalect llg/kg 
M 
400 llg 
M 100-
Feldberg c CL 400 llg 
& M 
Wei ME 
1981 1. 6 llM 
BE 
400-800 
llg 
BE 
200-400 
llg 
CL-vagot- M 400 
omized llg 
CL-stellate M 400 
removed llg 
PB as MPK BE 
Moss & D nan-vagot. 15 nM 
Scarpelli 
1981 PB as MPK BE 
vagot. 15 nM 
Route of Efrects on the 
Admin. Heart 
IV RI 
IVT tachycardia 
IC t 
sc t 
IVT NE 
IVT tachycardia 
IC t 
IVT tachycardia 
IVT NE 
IC t 
IC NE 
Effects 
BP 
RI 
small, 
t 
t 
t 
trans. 
NE 
t 
' 
? 
? 
t 
+ 
on 
trans. 
t 
Other 
Observations 
Both effects 
long-lasting 
Both effects 
long-lasting 
I ...... 0 
N 
although in most studies, f decreases (see Table 2). Convulsions, 
resulting in an improved ventilation due to increases in f, were noted 
by early investigators such as Wood and Cerna (see 7), Filehne (see 
7), Cushny and Lieb (8), and Schmidt and Harer (39) when the 
cumulative morphine dose was large. The effects of V/T are less 
certain; the depression of V/T has been described as being both 
greater than or less than the depression of frequency. Interest in 
which of these two parameters ' was more affected by morphine has 
c~ntinued throughout the years, for it was hoped that the overall 
depression of ventilation by morphine could be explained on the basis 
of a simple depression of f and/or V/T. 
The results of the curre~t study may help to shed a new light on 
the discr~pancies in the literature as regards the effects on f and 
V/T. Maximum cumulative doses of morphine in most bolus injection 
studies appear not to have exceeded 20 mg/kg, in contrast to the 
totals reached by constant infusion in this study (Eupneic group: 135 
+/- 28 mg/kg; Apneustic group: 166 +/- 23 mg/kg). An arbitrary 
division of previous studies can be made, such that those studies in 
which effects are produced by small, cumulative doses of morphine (<15 
mg/kg) are viewed independently of those studies dealing with larger 
cumulative doses of morphine (>15 mg/kg) (studies dealing with 
microinjection/iontophoresis will be examined later). A spectrum of 
ranges of bolus injections has thus been constructed, with two general 
divisions: "low" and "high". 
In the bolus injection studies in which low doses of morphine 
were administered, f and V/T were reported to be decreased, f 
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apparently being the more affected of the two variables. Those 
studies in which higher doses of morphine were employed, reported f to 
be increased, and convulsions (along with gasping) to be present. 
These observations correlate well with phases A and D, respectively, 
seen in the Eupneic group in this study. During phase A, when the 
cumulative levels of morphine were still low, both f and V/T were 
depressed to a nearly equal extent. Through phases B and C, however, 
it would appear that f indeed was the variable affected more by the 
increasing morphine level. The stimulation of ventilation by higher 
doses of morphine reported in the literature parallels phase D, during 
which the V/tot is not significantly different from control due to the 
large increase in Vg. Convulsions were often observed during this 
terminal phase, in agreement with. other studies (7,8,39). 
The transition between the effects of low and high doses of 
morphine might be the effects noted during phases B and C. The 
assumption of a periodic character in phase B agrees with the 
observations of Barbour (1) and Jackson (23); the disappearance of the 
pattern as the cumulative doses of morphine rises (as phase C begins) 
correlates with a similar observation also made by Barbour (1). The 
decrease in f/n and the increase in V/Tn noted in phase B (which led 
to a much reduced V/n) may correspond to the later observation of 
Schmidt and Harer of a decreased f and increased V/T (though they made 
no mention of the nature of the pattern at the time the measurement 
was made; morphine dose was 1-5 mg/kg). 
Phase C apparently has no correlates in the literature, possibly 
due to the inherent differences between the bolus injection and 
105 
constant infusion technique. Obvious parallels have been drawn 
between the current study and previous studies, regarding the effects 
observed at low and high doses of morphine. However, because during 
bolus injection studies the transition from low to high doses was 
nearly instantaneous, rather than gradual as in this infusion study, 
those effects marking the transition may have been lost (perhaps due 
to other factors, such as the marked depression of circulation that 
r 
can occur with larger bolus injections). The constant infusion 
technique stretches out the spectrum of effects, allowing phases of 
different ventilatory patterns to be distinguished. 
Studies employing discrete injections of morphine or related 
substances have failed to pro~ide more than a gradual description of 
the possible sites of action mediating respiratory effects of the 
opioids. Apparently, however, met-enkephalin and beta-endorphin (in 
the amounts tested) both cause depression of f and V/T (V/T being the 
more affected of the two variables) when injected at the ventral 
surface of the brainstem (18), intraventricularly (17), or 
intracisternally (30). Only one microinjection study employed 
morphine (17); when injected into the fourth ventricle and 
subarachnoid space, a decrease in f with no effect on V/T was noted. 
Allowing for differences between the studies, it is apparent that the 
opioid substances (in the doses tested) exert a similar effect on f. 
The depression of f and V/T in phase A of this study possibly 
correlates with the effects of the endogenous opiates cited above; 
indeed, Florez et al. (17) found an intraventricular injection of 
morphine to exert a similar effect as that which was injected 
intravenously. The similar effects may be due to the substances 
acting at similar sites in the lower brainstem; a more exact 
localization of such sites will have to await further studies. 
Alterations in the eupneic pattern by morphine as seen in this 
study do not lend themselves · to speculation regarding possible 
mechanisms in terms of the inspiratory off-switch model of the 
respiratory controller because changes in the duration of inspiration 
were not quantitated. A qualitative evaluation of such changes, as 
will be made in the discussion concerning the effects of morphine on 
the apneustic pattern, is not as easily accomplished in eupneically 
respiring cats. Some general remarks, however, contrasting eupnea 
with . gasping in terms of the off-switch model will be made in a 
following section. 
The actions of morphine on f and V/T in eupnea are more complex 
than previously recognized by most investigators. Kokka's remark, "it 
appeared a separation of the respiratory response to morphine was 
exhibited with increasing doses; the depression of ventilation 
predominated at the lower doses, but was minimized at higher doses" 
(26) is apropos in light of the present results. In this study, the 
depression of ventilation apparent in the earlier phases was overcome 
by the gradual increase in gasping ventilation. The two types of 
respiratory activity that occurred simultaneously in phase C (eupnea, 
gasping) would appear to be the result of two distinct and separate 
kinds of activity. As such, the first type of inspiratory activity 
would determine eupneic respiratory cycles. A second type of 
inspiratory activity, apparently activated as the cumulative levels of 
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morphine increased, would determine the gasping ventilation. By the 
final phase D, it would appear as though the first type of activity 
had disappeared, since gasping predominated during this phase. 
Discussion concerning the second type of activity will be deferred to 
a later section. 
2. Morphine effects on blood pressure and heart rate 
During the initial phase of the morphine infusion (as when the 
cumulative level of morphine was low), a non-significant increase· in 
MAP over the control level was seen; this was followed by a 
significant decrease in MAP, lasting the remaining three phases. The 
evidence in the literature of morphine-induced catecholamine release 
from the adrenal medulla (13,43) would account for this immediate, 
transient pressor response. The gradual hypotension that developed 
over the course of the infusion agrees with the observations of 
Wallenstein, with the exception that he observed this prolonged 
decrease in MAP to occur at low levels of morphine (43). Also in 
agreement with the present results are the studies of Feldberg and Wei 
(14,15), in which both intracisternal and intravenous injections of 
morphine produced a gradually developing fall in MAP. The "morphine 
tolerance" effect noted by Schmidt and Livingston (40) and Evans et 
al. (13) was not apparent, since MAP continued to decrease (rather 
than recover to control levels) over the course of the infusion. 
The slight decrease in HR noted during phase A need not have been 
an opioid-induced bradycardia; HR may have been slowed reflexly due to 
the slight increase in MAP. Over the next three phases, though MAP 
was declining by a significant amount, HR did not increase above 
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control levels, probably because rates were quite elevated already. 
The minimal changes in HR are more difficult to reconcile with the 
results of previous studies; only Wallenstein (43) reported a 
transient decrease in HR followed by an increase in rate, an effect 
observed with larger doses of morphine. Feldberg and Wei (14,15), 
whose studies showed changes in MAP similar to those seen in the 
present study, 
tachycardia (due 
observed a long-lasting fall in HR, though a 
to increased sympathetic discharge to the heart) 
could occur if morphine and beta-endorphin were injected 
intraventricularly. Moss and Scarpelli (30), in non-vagotomized 
dogs, had observed a decrease in HR (in addition to the decrease in 
MAP) upon intracisternal administration of morphine (an effect 
abolished by vagotomy). 
Two suggestions have been put forth previously as to possible 
mechanisms for these effects. The first hypothesis is a decrease in 
sympathetic outflow to the heart and circulation (13,14,15,43). Thus, 
MAP declines in spite of an increasing PAC0/2 and decreasing PA0/2 
level, which would be expected to increase sympathetic outflow to 
certain circulatory beds as a consequence of chemoreceptor activation. 
The slowing of HR, due to : (a) direct depressant effects of morphine 
on the heart itself; (b) chemoreceptor activation (in the absence of 
an increased ventilation); (c) a combination of (a) and (b), would 
therefore be reinforced by a decrease in sympathetic tone to the 
heart. A 
facilitated 
second hypothesis 
alone (28,29) or 
is 
in 
that central vagal pathways are 
combination with a decrease in 
sympathetic outflow (thus decreasing MAP and HR; 30) or an increased 
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sympathetic discharge (transient pressor response which is centrally 
and per}pherally mediated; 14,15,43). 
The changes in MAP seen in the Eupneic group are consistent with 
either of the two proposed mechanisms. The minimal changes in HR, 
however, are more difficult to assess. During phases B and C, as 
V/tot is increasing toward control levels, HR is also increasing. 
The progressive increase in V/tot (which is not necessarily a 
consequence of chemoreceptor activation, discussed subsequently) may 
be sufficient to induce small increases in HR; a reduction in 
sympathetic outflow, with or without a facilitation of vagal pathways, 
would then counterbalance the increase. The net result, then, would 
be an insignificant change in HR during phases B and C. A small 
• 
decrease in HR during phase D, concurrent with the decrease in V/tot 
this phase, may reflect the absence of the reflex increase, thus 
leaving whatever retarding influences there were to predominate. 
To what extent the changes in cardiovascular variables are due 
to changes in arterial gases as opposed to direct effects of opiates 
is not clear in the literature. The view of Moss and Scarpelli (30) 
does not account for the interaction of primary effects (produced in 
each system through discrete and separate pathways) to produce 
secondary effects. In the present study, the hypercapnic hypoxia 
grad~ally developing over the course of the infusion may activate 
either chemoreceptors (if still functional) or the "gasping" 
respiratory controller (see subsequent discussion); either could 
induce reflex circulatory changes. This does not exclude, however, 
the possibility of direct effects of morphine on the cardiovascular 
system by either central mechanisms (effect on brain stem 
cardiovascular centers) or peripheral mechanisms (direct depressant 
effect of morphine on the heart or release of catecholamines form the 
\ 
adrenal medulla). 
c. Alterations in Respiratory and Cardiovascular Variables in 
Apneustically Breathing Cats 
1. Alteration of the apneustic pattern 
The apneustic pattern is characterized by inspiratory activity 
which starts normally, but does not decline abruptly when it reaches 
its maximum level. Instead, it continues at a plateau level for 
several seconds to minutes (5~45). Thus, an imbalance exists between 
inspiratory and expiratory phase durations (Ti and Te, respectively) 
such that Ti is greatly prolonged. In contrast, in the eupneic 
pattern timings of Ti and Te are of the same order of magnitude, the 
Ti/Te ratio being 0.5-0.7 (5). 
The crucial region in the dorsolateral pons whose activity must 
be disrupted to induce apneusis in vagotomized cats is the nucleus 
parabrachialis medialis (NPBM). Apneusis can be abolished or markedly 
diminished by additional transactions at the border of the pons and 
medulla, intermediate pontine levels (partial reversal) or limited 
midl~ne lesions at the pontomedullary border. Such results, as well 
as electrophysiological studies (5), have suggested the existence of a 
pontine "apneustic center" that can promote apneusis if released from 
rostral and vagal afferent influences. 
Alternatively, apneusis can be modeled in terms of the 
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"inspiratory off-switch mechanism" (5,45). Briefly, a centrally 
generated inspiratory activity (CIA) (originating at an undefined site 
within the brainstem respiratory controller) is received by 
inspiratory cells in the ventrolateral nucleus of the solitary tract, 
which also receive input from pulmonary stretch receptors via vagal 
afferents. CIA is also received by respiratory motorneurons of the 
spinal cord. Efferent activity from this pool of summated inspiratory 
and vagal activity is conveyed to a "switch neuron pool"; when the 
threshold ("off-switch threshold") of these neurons is reached, the 
inspiratory activity generation is inhibited and inspiration 
terminated (5,45). The off-switch threshold appears to be independent 
of vagal input, so that the continuously increasing CIA signal alone 
will eventually cause the inspiratory cells to reach off-switch 
threshold. At any time earlier than this, a sufficient lung inflation 
signal can sum with the CIA and cause the cells to reach off-switch 
threshold early. 
Cells in the pneumotaxic center fire tonically during normal 
(vagus-intact) breathing, and this output feeds into the inspiratory 
off-switch. When the NPBM is lesioned, inspirations are prolonged; 
thus, it appears the off-switch threshold is raised. The NPBM output, 
then, seems to directly sum with the CIA and vagal afferent activity 
to aphieve threshold. Eliminating both the NPBM and vagal inputs to 
the switch neuron pool would cause inspiration to be prolonged 
(apneusis) because threshold would take even much longer to attain. 
The occurrance of apneusis can be influenced by several 
peripheral and central inputs. For example, increases in body 
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temperature (carefully controlled in the present study) have been 
shown to produce substantial reductions in respiratory duration, 
converting an apneustic to a eupneic pattern (5). The influence of 
elevating PC0/2 however, is not as clear. It is generally agreed 
that the C0/2 stimulus exerts two different actions which, in the 
vagotomized cat, are roughly proportional: 1) an excitatory effect on 
CIA generation and 2) an inhibitory, threshold-increasing action on 
the off-switch mechanism. Thus, no change in the duration of 
inspiration occurs. Studies by von Euler et al. (12) in the apneustic 
cat failed to show major or consistent changes in the duration of 
apneustic inspiration in response to changes in PC0/2 (under normoxic 
conditions). These investigators suggested that this proposed dual 
effect of C0/2 persists in apneustic breathing (12). St. John (35), 
however, found that under normoxic or hyperoxic conditions, elevations 
of PC0/2 typically resulted in ·prolongation of Ti, Te, and the total 
respiratory cycle duration (Ttot). In addition, he observed an 
augmentation of the apneustic depth (i.e. increased inspiratory 
activity) and an increased inspiratory duration (increased off-switch 
threshold). 
Hypoxia-induced changes in the apneustic pattern have been less 
thoroughly investigated. The studies of Tang (42) and von Euler (12) 
had ,suggested hypoxia to 
neither considered the 
diminish the inspiratory duration, though 
possible site of mediation (carotid 
chemoreceptors or central nervous system) responsible for the change. 
Other studies, however, showed direct pharmacological stimulation of 
carotid chemoreceptors by cyanide could cause both a premature 
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development of an apneustic inspiratory spasm and/or a premature 
termination of the inspiratory phase (35). 
In the same study examining the effects of hypercapnia on the 
apneustic pattern, St. John found the effect of decreasing P0/2 to 
hypoxic levels (at isocapnia) resulted in significant diminutions of 
the apneustic inspiratory and expiratory durations, and the total 
apneustic breathing cycle (35). Moreover, an increase in depth was 
observed in most cases following such a P0/2 change. Elevations of 
PC0/2 under hypoxic conditions caused no systematic change in Ti, Te, 
or Ttot, but following bilateral carotid sinus nerve section, normoxic 
hypercapnia again caused significant increases in Ti, Te, and TTOT. 
The responses to hypoxia were markedly different in cats without 
peripheral chemoreceptors. Thus, the results obtained subsequent to 
P0/2 decreases implied hypoxia to be causing an increase in 
inspiratory activity and a reduction in the inspiratory and expiratory 
off-switch threshold. St. John concluded his data to be consistent 
with the notion that hypoxia-induced alterations of apneusis were the 
net result of carotid chemoreceptor stimulation and brainstem hypoxia. 
The foregoing considerations of various influences that affect 
the apneustic pattern are important in light of the results of the 
present study. The anecdotal observations of Breckenridge and Hoff 
(4) t and Ngai (31) that morphine attenuates apneusis have been 
confirmed and extended by the present study. Though not specifically 
examined in this study, the possible mechanisms through which this 
effect was mediated merits speculation. 
In terms of the model based on that of the inspiratory off-switch 
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model, cats in this study were deprived of input from the NPBM and 
vagal afferents. Thus, for CIA to reach threshold sooner, either the 
inspiratory activity was augmented or the switch threshold lowered. 
As mentioned in the results sectio~, the morphine infusion began 
shortly after apneusis was induced in 4 of 6 cats.. In the 2 cats in 
which apneusis was allowed to continue for five minutes or so after 
induction, no sign of decreasing inspiratory duration was evident • 
. 
Though some hypoxia was undoubtedly present, as evidenced by the 
higher frequency of gasping during the control phase (P) in the 
apneustic group, it did not appear to be influencing inspiratory 
duration. When the morphine infusion began, however, all cats 
demonstrated a marked and ~early immediate change in inspiratory 
• duration, decreasing it in such a way that although apneusis was still. 
present, the duration and intensity of the apneustic holds were 
reduced. This effect of morphine appears to be similar to the direct 
stimulation of peripheral chemoreceptors by cyanide mentioned 
previously, a stimulation which increases inspiratory activity. The 
augmentation of inspiratory activity would account for the increase in 
ventilation through phase B (apneusis attenuation). 
During phase C, however, the apneustic pattern recurs, 
accompanied by increased gasping (which had decreased during phase B). 
MAP tduring this phase is quite reduced, and gasping ventilation 
largely increased. A hypercapnic hypoxia could reasonably be assumed 
to be present because of the hypoventilation existing during phases A 
and B, though that of phase A was of relatively short duration in most 
cats. The increase in gasping ventilation would support this 
contention. 
It is here that speculation becomes complex because of the two 
separate, simultaneous types ·of ventilation. It would appear that two 
respiratory off-switch mechanisms are in operation. First, there is 
the off-switch mechanism that determined the duration of the apneustic 
inspirations; in this mechanism, inspiratory activity appears to have 
been augmented in th~ early phases. The second off-switch mechanism, 
apparently activated as the cumulative level of morphine increased, 
was responsible for the gasping ventilation. Use is made of the term 
"off-switch mechanism" because it encompasses the possibility that 
either inspiratory activity or threshold level may have changed. This 
secondary ventilatory activity will be considered separately in·the 
following section. 
From the work of St. John (35), hypoxia appears to increase the 
CIA and 
increases 
reduce the off-switch threshold; 
CIA as well as the threshold. 
hypercapnia, however, 
Though the literature 
generally agrees that C0/2 responsivity is decreased after morphine, 
it may be that this is only true at lower doses. Also, lesioning of 
the pneumotaxic center does not necessarily entail a decrease in C0/2 
responsivity (12). Thus, if a hypercapnic hypoxia exists by phase C, 
it may be th~t the effects of hypercapnia prevail at this time. CIA 
would thus remain augmented but a net increase in off-switch threshold 
would increase inspiratory duration. The apneustic holds which 
reappear during phase C are of shorter duration and intensity than 
those seen during phase P (speaking qualitatively). However, 
frequency remains significantly elevated over control during phase C; 
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it is the significant decrease in V/T which accounts for the change in 
ventilation during this phase. 
decreased inspiratory activity. 
This decrease in depth indicates a 
Possibly, the augmentation to CIA 
which existed 
threshold is 
CIA and those 
during phases A and B was decreased, but the switch 
lowered due to hypoxia. Mismatches between changes in 
of the inspiratory off-switch have been postulated to 
exist (35), so such a suggestion is in the realm of possibility. 
Hypercapnia, then, may not have any effects, as postulated by von 
Euler et al. (12). 
Apneusis is nearly 
appear the first type 
second type predominates 
absent during the final phase D. It would 
of respiratory activity "drops out" as the 
during this phase. If mismatches in the 
level of CIA and the off-switch threshold are generated by the higher 
levels of morphine, it may be that the relationship between the two 
are so disrupted by the final phase that the first type of respiratory 
activity is no longer functional. 
Morphine, thus, has fundamental actions on the neurons of the 
respiratory controller, 
threshold occurring as 
with secondary effects on the off-switch 
a result of the hypercapnia and hypoxia 
generated as a result of that fundamental action, the nature of which 
still remains to be elucidated. 
2. ,Effects of morphine on f{AP and HR 
The gradual decrease in MAP during the course of the infusion 
generally resembled those seen in the Eupneic group with the 
followoing exceptions. First, the MAP during phase P was tremendously 
elevated, most probably due to the apneusis existing at this time. 
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Secondly, a pressor effect was not evident during phase A as it seemed 
to be in the Eupneic group. Lastly, MAP had fallen to much lower 
levels by phase D, when compared to the level of the Eupneic group 
during its phase D. The morphine tolerance effect was not apparent in 
this group, a similar finding to that seen in the Eupneic group. 
The gradual decrease in heart rate which· occurred over the course 
of the infusion does not become significant until the final phase. 
The rate is extremely elevated throughout the course of the infusion, 
most probably due to the hypoventilation (relative to a normal 
ventilation) that existed. The decrease in rate is in agreement with 
the literature and may be a reflection of a direct depressant effect 
of morphine on the heart, or a decrease in sympathetic tone; 
facilitation of vagal pathways is not a consideration in this group, 
since the animals were vagotomized. 
D. Induction of Gasping in the Eupneic and Apneustic Groups 
Gasping has been shown to represent a respiratory pattern that 
differs fundamentally from both eupnea and apneusis. Not only does 
the pattern of phrenic nerve activity during gasping differ markedly 
from that during eupnea or apneusis, but also (in contrast to eupnea 
and apneusis) gasping is not systematically altered by stimuli acting 
on the peripheral or central chemoreceptors (36). The observation 
that diminutions of PA0/2 cause gasping in both carotid chemoreceptor 
intact and denervated cats leads to the conclusion that peripheral 
chemoreceptor mechanisms are not responsible for hypoxia-induced 
changes in gasping. As St. John et al. (36) noted, the augmentations 
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of gasping 
controller 
frequency 
for gasping 
with 
may 
reductions of 
be directly 
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PA0/2 imply that the 
sensitive to the partial 
pressures of oxygen within the medulla, a concept which is not new. 
In the present study, cats breathing eupneically or apneustically 
demonstrated an increased frequency of gasping as the cumulative 
levels of morphine increased, an observation agreeing with the 
literature. A gradual decrease in MAP is seen to occur in bQth 
groups, falling to or below the lower limit of the autoregulatory 
range of the cerebral circulation; this, along with the 
hypoventilation that occurred in each, undoubtedly contributed to a 
brainstem hypoxia, which has been shown to release gasping mechanisms 
(36). 
In phase C, for both groups, gasping appeared superimposed on 
either eupnea or apneusis. Evaluation of the appearance of the 
ventilatory 
two kinds 
pattern during this phase has led to the conclusion that 
of respiratory activity are present, each of which can be 
discussed in terms of the.off-switch model. In the Eupneic group, the 
normal off-switch operating would determine eupneic respiratory 
cycles; in the Apneustic group, an altered mechanism (elimination of 
vagal afferent and pneumotaxic center activity) would determine 
apneustic respiratory cycles. In both groups, brainstem hypoxia would 
rele~se a gasping mechanism. Inspiratory activity would reach a 
maximum within a few hundred milliseconds of its onset and cut off 
sharply, rather than augmenting gradually (45). In other words, the 
inspiratory threshold is reached nearly instantaneously. The 
strongest evidence in this study that two mechanisms are operating 
CHAPTER VI 
CONCLUSIONS 
The results of the current study may help to shed a new light on 
discrepancies existing in the literature as regarding the effects of· 
morphine on frequency and tidal volume during eupneic breathing. In 
previous bolus injection studies in which ~ow doses of morphine ~ere 
administered, frequency and tidal volume were reported to be decreased 
(frequency apparently being the more affected of the two variables). 
Those bolus injection studies employing higher doses of morphine 
reported frequency to be increased, and convulsions (accompanied by 
gasping) to be present. These observations correlate well with phases 
A and D, respectively, seen in the Eupneic group in this study. The 
transition between the effects of low and high doses of morphine may 
be those effects occurring during phases B and C. The assumption of a 
periodic character in phase B agrees with the observations of Barbour 
(1) who also noted the pattern to disappear as the cumulative dose of 
morphine increased. Phase C apparently has no correlates in the 
literature (as to the effects on frequency and tidal volume), possible 
due to the inherent differences between the bolus injection and 
constant infusion. technique. The constant infusion technique thus 
stretches out into a broader spectrum the effects of morphine, 
allowing phases of different ventilatory patterns to be distinguished. 
Previous studies observing morphine to attenuate apneusis (4,31) 
have been confirmed and extended by the present study. The results 
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indicate morphine to have a fundamental action on the respiratory 
controller, effecting changes in the off-switch ~echanism controlling 
the duration of inspiration in such a way as to attenuate the duration 
of apneustic inspiratory holds. 
Lastly, the gasping that appeared superimposed on either eupnea 
or apneusis has led to the conclusion that two kinds of respiratory 
activity are present. In addition to the normal (eupneic) or altered 
(apneustic) off-swi~ch mechanism operating, a second mechanism in 
which the inspiratory threshold is reached nearly instantaneously 
(gasping) would also be active (possible triggered by a brainstem 
hypoxia due to the developed hypoventilation/hypotension over the 
course of the infusion). The strongest evidence in.this study that 
two off-switch mechanisms are operating simultaneously lies in the 
records of the apneustic group. Gasps, with extremely shortened 
durations of inspiration are seen superimposed on apneustic breaths 
with prolonged inspirations. The hypoxia possibly responsible for the 
gasping ventilation could be considered a secondary effect of the 
fundamental action of increasing morphine levels on respiratory 
controller neurons (to which the disappearance of both eupnea and 
apneusis during phase D, leaving gasping to predominate, may be 
related). The present results thus appear to reflect a combination of 
primary and secondary effects of morphine on respiratory rhythm 
j 
generation. 
2. 
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APPENDIX A 
Table of respiratory and cardiovascular variables quantitatively 
measured during the progression of phases in the Eupneic and Apneustic 
groups. Eupneic (E) and Apneustic (A) group values are for measured 
(f/n, V/Tn, f/g, V/Tg, HR, MAP) and calculated (V/n, V/g, V/tot) 
variables. Values represent mean and standard error of 6 cats in each 
group, with the exception of heart rate in the Eupneic group (where 
n=4) and the Apneustic group (n=3). Abbreviations: f/n = frequency, 
normal pattern; V/Tn = tidal volume, normal pattern; V/n = 
ventilation, normal pattern; f/g = frequency, gasping pattern; V/Tg = 
tidal volume, gasping pattern; 
' 
V/g = ventilation, gasping pattern; 
V/tot = total ventilation (sum of V/n and V/g); HR = heart rate, ·MAP = 
mean arterial pressure. Phase abbreviations for the Eupneic group: P 
= control; A initial depression; B = periodic breathing; C = 
recovery from periodicity; D = gasping. Phase abbreviations for the 
Apneustic group: P = control; A = apneusis attenuation; B = apneusis 
reversal towards eupnea; C = apneustic gasping; D = gasping. 
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Appendix 
Variables Crouo p A B c D 
fn E 25.8± 3.0 19.5± 3.0 . 10.9:!: 5.1 29.2± ~f~4 6.2± 4.3 
breaths/min A 0.6± 0.1 1.5± 0.2 2.4± 0.6 3.5:!: 0.7 0.7± 0.5 
VT E 39.0± 5.6 28.6± 4.1 58.0± 11.2 32.5± 7.4 9.7± 4.8 
n 
ml A 92.5:!: 10.9 94.3±12.1 83.5± 12.2 47.1:!: 13.6 14.1± 11.8 
Vn E 981.0±141 .5 531.3±72.9 444.4±122.6 820.8±217.8 115.6:!: 74.9 
ml/min A 49.7± 9.7 145.6±32.8 207.1:!: 54.4 132.8± 29.5 19.8± 13.6 
fg E 0.8 1.1:!: 0.4 1.6± 0.6 3.6± 1.6 9.8± 4.2 
breaths/min A 1.4± 0.7 3.2± 1.2 3.4± 1.2 5.2± 1.4 5.3± 0.7 
v!g E 1.7 16.7:!:13.6 22.6:!: 11.3 32.7:!: 10.7 75.7:!: !4.0 
ml A 9.1± 6.0 35.7±14.3 22.6:!: 6.8 48.7± 15.3 68.8:!: 11.8 
Vg E 0.8 57.8±48.9 41.0± 17.2 99.9:!: 50.1 558.8± 76.6 
ml/min A 23.2:!: 13.4 137.3±68.5 108. 9± 51.0 200.1± 65.6 341.2± 60.7 
VTo: E 981.8:!:141.4 589.1±67.2 485.4±127.4 920. 7:!:208 .1 671.4±119 .2 
ml/min A 72.9± 18.2 282.8:!:54.5 316 ± 62.0 332.9± 64.6 360.9± 69.7 
HR E 201 ! 22 157 ±1JJ 196 ! 14 214 :!: 24 190 :!; 46 
beats/min A 277 ! 16 278 :!: 4 263 :!: 16 252 :!: 18 216 :!; 5 
!-!AP E 135 :!: 4.4 158 :!:21.9 96 ! 5.0 82.5:!: 8.8 74 ! 7.5 
nunHg A 195 ! IS 101 ±14 83 :!: 9 69 :!: 7 56 ± 4 
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